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O friend, for the morrow let us not worry 
This moment we have now, let us not hurry 
When our time comes, we shall not tarry 
With seven thousand-year-olds, our burden carry. 
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 II 
Abstract 
 
With the constant increase in the age of the population in many countries of the world, 
understanding the molecular mechanisms of aging is of central importance. This increase in 
the age of societies in developed countries has been achieved through improvements in 
healthcare and drug development. However, aging is associated with a myriad of diseases that 
not only affect the quality of life for the elderly, but also impose a major challenge on the 
socio-economic and healthcare systems. Thus, gaining a better understanding of the aging 
process at the molecular level could lead to novel therapies against aging and age-associated 
diseases. 
 
Functional decay of somatic stem cells, which leads to hampered tissue regeneration is 
one of the main hallmarks of aging. Human embryonic stem cells (hESCs) can replicate 
indefinitely while maintaining their undifferentiated state and, therefore, are immortal in 
culture. This capacity is among others dependent on enhanced protein homeostasis 
(proteostasis) mechanisms, since any imbalance in protein quality control could potentially 
compromise the resulting lineage of cells. Decline in the proteostasis is also known as a main 
contributor to aging. Thus, studying proteostasis of hESCs is a novel paradigm, that will not 
only help us gain a better understanding of hESC biology, but could also provide a link 
between hESC immortality, organismal longevity and stress resistance.  
 
In the frame of this study, we aimed to investigate the regulation of proteostasis in 
hESCs and its relevance to stemness, stress resistance, aging and age-associated diseases. We 
tried to define key candidates responsible for enhanced proteostasis in hESCs by comparing 
hESCs and differentiated cells using quantitative proteomics and RNA-sequencing, and were 
able to identify several proteostasis-related proteins, which are differentially expressed. 
Recent studies demonstrate that hESCs have increased proteasome activity in comparison to 
their differentiated counterparts. This increased proteasome activity was found to be essential 
for hESC identity and their differentiation into neural cells. Elevated expression of PSMD11, 
a subunit of the 19S proteasome, is required for the enhanced proteasome activity in hESCs. 
In addition, ectopic expression of rpn-6 (C. elegans orthologue of PSMD11) was sufficient to 
confer proteotoxic stress resistance and extend lifespan in this model organism. In this study 
we show that PSME4, a distinct form of proteasome activator, resembles the high expression 
levels of PSMD11 in hESCs. However, unlike PSMD11, this protein was found to be 
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dispensable for stem cell function and organismal longevity under normal growth conditions.  
 
Besides the proteasome, we also sought to understand how the chaperome regulates 
immortality and aging. The human chaperome is formed by 332 chaperones and co-
chaperones that regulate the folding and function of proteins. We show that human pluripotent 
stem cells exhibit dramatic differences in expression of molecular chaperones. In particular, 
we observed much higher expression and increased assembly of the TRiC/CCT complex, a 
chaperonin that facilitates the folding of 10% of the proteome. This highly conserved 
molecular machine forms a~1MDa complex in the cytosol of eukaryotic cells, consisting of 
two back-to-back rings, each containing seven to nine subunits of ~60 kDa. TRiC/CCT is 
responsible for the folding of many essential proteins, including components of the 
cytoskeleton such as actin and tubulin or cell cycle regulators, and its dysregulation is 
associated with a myriad of diseases including cancer and neuropathy. We found that ectopic 
expression of a single subunit (CCT8) is sufﬁcient to increase TRiC/CCT assembly. 
Moreover, enhanced TRiC/CCT assembly is required for the striking ability of pluripotent 
stem cells to maintain proteostasis of aggregation- prone huntingtin (HTT), the mutant protein 
underlying Huntington’s disease (HD). Since the levels of CCT subunits are further decreased 
in somatic tissues during organismal aging, we examined whether modulation of CCT8 can 
delay the aging process and proteostasis dysfunction by using C. elegans as a model 
organism. Notably, upregulation of CCT8 levels in somatic tissues triggers TRiC/CCT 
assembly and extends organismal lifespan particularly under proteotoxic conditions. Ectopic 
expression of CCT8 also ameliorates the age-associated demise of proteostasis and corrects 
proteostatic deﬁciencies in worm models of Huntington’s disease. Our results suggest 
proteostasis is a common principle that links organismal longevity with hESC immortality. 
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Zusammenfassung 
 
 
Aufgrund der steigenden Lebenserwartungen in den Bevölkerungen vieler Länder, 
entwickelt sich die Erforschung der molekularen Mechanismen des Alterns zu einer wichtigen 
wissenschaftlichen Diziplin. Der beeindruckende Anstieg der durchschnittlichen 
Lebenserwartung in Industrieländern wurde durch herausragende Verbesserungen des 
Gesundheitswesens und der Arzneientwicklung ermöglicht. Dies ist jedoch mit extremen 
Herausforderungen verbunden, die das wachsende Aufkommen altersbedingter Krankheiten 
sowohl an das fiskale, als auch das Gesundheitssystem stellt. Ein detaillierteres Verständnis 
des Alterungsprozesses auf molekularer Ebene könnte daher zu verbesserten Therapien gegen 
solche Krankheiten im speziellen und den Alterungsprozess im Allgemeinen führen. 
 
Funktionaler Abbau somatischer Stammzellen, welcher zu einer gestörten 
Geweberegeneration führt, ist eines der Kennzeichen des Alterns. Dagegen behalten 
menschliche embryonale Stammzellen (hES-Zellen) ihre Replikationsfähigkeit und ihren 
undifferenzierten Status auf unbestimmte Zeit bei und sind daher in Zellkultur theoretisch 
unsterblich. Diese Eigenschaft beruht unter anderem auf verstärkten Proteinhomeostase- 
(Proteostase-) mechanismen, da ein Ungleichgewicht in der Proteinqualitätskontrolle die 
resultierende Zelllinie negativ beeinträchtigen kann. Eine Abschwächung der Proteostase 
stellt zudem einen Hauptfaktor für den Alterungsprozess dar. Eine eingehendere 
Untersuchung der Proteostase von hES-Zellen dient daher nicht nur einem besseren 
Verständnis der hES-Zellbiologie, sondern könnte auch eine Verbindung zwischen der 
Unsterblichkeit von hES-Zellen, organismischer Langlebigkeit und Stressresistenz herstellen. 
 
Das Ziel der vorliegenden Studie war die Untersuchung der Proteostaseregulation in 
hES-Zellen und deren Relevanz für die Stammzellenfähigkeit, die Stressresistenz, den 
Alterungsprozess und die Entstehung altersbedingter Erkrankungen. Durch den Vergleich 
quantitativer Proteomanalyse- sowie RNA-Sequenzierungdaten von hES- und differenzierten 
Zellen wurden mehrere potentielle Kandidatenproteine identifiziert, die in Zusammenhang 
mit erhöhter hES-Zellproteostase stehen.  
 
Jüngste Studien zeigten, dass hES-Zellen eine erhöhte Proteasomaktivität im 
Vergleich zu differenzierten Zellen aufweisen. Diese verstärkte Proteasomaktivität ist 
essentiell für die Bewahrung der hES-Zellidentität und für ihre Differenzierung zu neuronalen 
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Zellen. Eine erhöhte Expression der 19S Proteasomuntereinheit PSMD11 ist notwendig für 
die verstärkte Proteasomaktivität in hES-Zellen. Darüber hinaus war die ektopische 
Expression von rpn-6, dem C. elegans-spezifische Ortholog von PSMD11, ausreichend, um 
Resistenz gegen proteotoxischen Stress sowie eine Verlängerung der Lebensspanne in diesem 
Modelorganismus zu verleihen. In dieser Arbeit zeigen wir, dass eine unterschiedliche Art 
von Proteasomaktivator, PSME4, ähnlich hohe Expressionslevel wie PSMD11 in hES-Zellen 
aufweist. Im Gegensatz zu PMSD11, ist jenes Protein jedoch verzichtbar für die 
Stammzellfunktion und die organismische Lebensdauer unter normalen 
Wachstumsbedingungen. 
 
Das menschliche Chaperom besteht aus 332 verschiedenen Chaperonen und Co-
Chaperonen, die die korrekte Faltung und Funktion von Proteinen gewährleisten. Wir zeigen, 
dass menschliche pluripotente Stammzellen dramatische Unterschiede in der Expression von 
molekularen Chaperonen aufweisen können. Wir beobachtetet im Besonderen eine deutlich 
verstärkte Expression sowie erhöhte Formierung des TRiC/CTT-Komplexes, einem 
Chaperonin, das für die Faltung von 10% des Proteoms verantwortlich ist. Diese 
hochkonservierte, molekulare Maschine formt einen etwa 1MDa Komplex im Cytosol 
eukariotischer Zellen und besteht aus zwei aufeinanderfolgenden Ringen aus jeweils sieben 
bis neun Untereinheiten mit einer Größe von ~60 kDA. TRiC/CCT ist für die Faltung vieler 
essentieller Proteine verantwortlich, darunter Komponenten des Cytoskeletts wie Actin und 
Tubulin, sowie Zellzyklusregulatoren. Die Dysregulierung dieses Komplexes ist mit einer 
Vielzahl von Krankheiten verbunden, darunter verschiedene Krebsarten und Neuropathien. 
Wir konnten herausfinden, dass die ektopische Expression einer einzigen Untereinheit 
(CCT8) ausreicht, um die Formierung von TRiC/CCT zu erhöhen. Erhöhter TRiC/CCT 
Aufbau war zudem notwendig für die herausragende Eigenschaft pluripotenter Stammzellen, 
die Proteostase des aggregationsanfälligen Huntingtin (HTT), einem Protein, dessen mutierte 
Form ursächlich für die Krankheit Chorea Huntington ist, aufrecht zu erhalten. Da die Zahl 
von CCT-Untereinheiten im somatischen Gewebe während des Alterns weiter fällt, 
untersuchten wir, ob die Modulation von CCT8 den Alterungsprozess und die 
Proteostasedysfunktion des Modelorganismus C. elegans hinauszögern kann. Die 
Hochregulierung der CCT8-Level in somatischen Geweben leitet die Formierung des 
TRiC/CTT-Komplexes ein und verlängert die organismische Lebensdauer besonders unter 
proteotoxischen Bedingungen. Ektopische CCT8-Expression verbesserte zudem den 
altersbedingten Abfall der Proteostase und korrigierte die proteostatischen Defizite in 
 VI 
Wurmmodellen von Chorea Huntington. Unsere Ergebnisse deuten auf Proteostase als 
gemeinsames Prinzip hin, welches organismische Lebensdauer mit der Unsterblichkeit von 
hES-Zellen verbindet. 
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1 Introduction 
 
  
“It is remarkable that after a seemingly miraculous feat of morphogenesis, a complex 
metazoan should be unable to perform the much simpler task of merely maintaining what is 
already formed.”   George Williams, Evolutionary Theorist  
 
Understanding aging and development of remedies for it, as the ultimate cause of 
major diseases and death, has long been the uppermost in the minds of many. Aging research, 
however, has started to emerge as a scientific field only in the last three decades. This has 
been facilitated firstly by the discovery of specific genes, which were proven to have a direct 
effect on longevity, and also through the demographic shift in the developed countries. Since 
the second half of the 20th century, due to major improvements in medical care and drug 
development that leads to reduction in mortality, as well as reduced population growth rates, a 
steady increase in the age of the population could be observed in many developed countries. 
The world’s population above 65 years, for instance, is expected to double in 2040 compared 
to 2008 (Schoeni and Ofstedal 2010). This dramatic increase in age is not only associated 
with many excruciating age-related pathologies such as cancer, diabetes, cardiovascular or 
neurodegenerative diseases for individuals, but also puts a huge burden on the socio-
economic and healthcare system. It is therefore of huge importance to understand the 
molecular mechanisms underlying the aging process in a greater detail, so that therapies could 
be developed for the many age-associated pathologies, thus providing not only a longer, but 
also a healthier life for the elderly.  
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1.1 Evolution and hallmarks of aging 
 
1.1.1 Aging from an evolutionary perspective 
 
 
Aging is commonly defined as the progressive loss of physiological integrity, which leads 
to impaired function and increased vulnerability to environmental challenges, disease and 
death (López-Otín, Blasco et al. 2013) (Kirkwood 2005). Apart from species such as Hydra 
that do not exhibit any signs of increased mortality, reduced fertility or senescence over time 
(Dańko, Kozłowski et al. 2015, Schaible, Scheuerlein et al. 2015), almost all other organisms, 
including unicellular organisms that seem to undergo symmetrical divisions such as 
Escherichia coli, demonstrate phenotypes of aging (Stewart, Madden et al. 2005). From an 
evolutionary point of view, it seems counter-intuitive that such a phenomenon, which is 
associated with universal decline in functionality and evolutionary fitness, has not been 
opposed by natural selection. Theories that view aging as a programmed event, are mostly 
based on the argument that aging could “filter-out” the old and unfit, prevent over-crowding 
and thus benefit the overall fitness of the species. This theory, though supported by the 
observation that manipulation of a single gene could influence longevity drastically 
(Friedman and Johnson 1988, Kenyon, Chang et al. 1993) faces some simple but serious 
challenges: firstly, the huge variation in aging among individuals from single cells in a 
specific population, to C. elegans or monozygotic human twins (Kirkwood 2005) argues 
against a tightly programmed event. Moreover, extrinsic factors such as predation, starvation, 
injury or cold are considered to be the main reasons for death in natural populations 
(Kirkwood 2005). Additionally, individuals with mutations that turn-off the programmed 
aging would eventually gain evolutionary advantage over the ones with the program; and thus 
thrive (Kirkwood 2005). Among other theories of aging, two seem to outweigh the others: 
“antagonistic pleiotropy” and “ the disposable soma” theory (Schulz, Palmarini et al. 2003). 
Antagonistic pleiotropy was put forward by the evolutionary theorist George Williams 
(Williams 1957) argues that genes which are advantageous in early life, could be the main 
drivers of aging later on. The disposable theory of aging is based on the difference in 
distribution of energy investment for repair and maintenance, mechanisms are highly energy 
consuming, in different compartments of the organism. Based on this theory, under natural 
conditions, more energy is allocated towards growth, reproduction and thermogenesis, and the 
soma needs to be maintained only as long as there is reasonable chance of survival. Minimal 
resources could be allocated for maintenance of somatic tissues, although this comes at the 
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expense of gradual damage accumulation, which will eventually lead to aging (Kirkwood 
2005). The main driver of aging, time dependant stochastic accumulation of damage, is 
regulated and could be alleviated by energy consuming repair mechanisms, as observed in the 
germline or embryonic stem cells (Kirkwood 2005, Vilchez, Boyer et al. 2012, Schultz and 
Sinclair 2016), which are downregulated in the soma. Consistently, many lines of research 
show that this phenomenon is plastic and resources could be re-allocated to the soma when 
the organism is challenged by extrinsic factors, upon ablation of germline stem cells, for 
instance (Hsin and Kenyon 1999). 
 
1.1.2 Hallmarks of aging 
 
The orchestrated efforts to understand the molecular mechanism of aging in the recent 
years have shed light to many aspects of aging and potential therapies against the pathologies 
associated with it. This research has facilitated the definition of aging as a molecular process 
and its characteristics. López-Otín and colleagues summarize the hallmarks of aging as 
following: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, 
deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell 
exhaustion, and altered intercellular communication (López-Otín, Blasco et al. 2013).  
 
 These hallmarks, according to López-Otín and colleagues could be categorized in 
three groups: primary, antagonistic and integrative hallmarks (López-Otín, Blasco et al. 2013) 
(Figure I). The primary hallmarks (genomic instability, mitochondrial DNA mutations, 
telomere loss, epigenetic alterations and loss of proteostasis) are negative and cause damage. 
Antagonistic hallmarks, depending on intensity could be detrimental or beneficial, which 
resembles the effects of hormesis (Schulz, Zarse et al. 2007, Gems and Partridge 2008, Rattan 
2008, Ristow, Zarse et al. 2009, Van Raamsdonk and Hekimi 2009, De Haes, Frooninckx et 
al. 2014, Schaar, Dues et al. 2015, Scialò, Sriram et al. 2016). These include deregulated 
nutrient sensing, cellular senescence and mitochondrial dysfunction. The mitochondrial 
toxicity caused by higher reactive oxygen species (ROS) production, for instance, could act as 
a double-edged sword. In low concentrations, this ROS could act as signalling molecules, 
which leads to activation of pathways with overall positive outcome for the cells (Schulz, 
Zarse et al. 2007, Scialò, Sriram et al. 2016). However, if this limit is exceeded, the outcome 
would be increased cellular damage and apoptosis (Simon, Haj-Yehia et al. 2000, Circu and 
Aw 2010). Finally, the accumulated damage will impinge upon tissue homeostasis by  
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diminishing the stem cell function or dysregulated cellular communication, which shifts the 
balance towards development of aging (Figure I.) 
 
 
1.2 Proteostasis in health, disease and aging 
 
Maintaining protein homeostasis (proteostasis) is a complex and tightly controlled task, 
which keeps the integrity of the proteome. Proteostasis has been one of the first biological 
processes which arose early after development of life on earth, and has been so central in 
development and evolution of life that no organism lacking mechanisms for proteostasis 
maintenance has survived to the present day (Powers and Balch 2013). Although unique for 
each species or even cell type, a proteostasis network (PN), consisted of complex and 
interconnected cellular mechanisms is developed to constitutively monitor the synthesis, 
Figure I. The hallmarks of aging and their interconnection.  The primary hallmarks are 
considered to be the main source of damage accumulation. Depending on the intensity, some 
beneficial stress response mechanisms could become detrimental (antagonistic hallmarks) Integrative 
hallmarks are the outcome of accumulated damage and chronic stress response, which eventually lead 
to imbalances in function and physiology of the organism and result in aging. Figure reprinted from 
(López-Otín, Blasco et al. 2013), with permission from Elsevier. 
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folding, degradation, localization and interaction of proteins (Vilchez, Saez et al. 2014). The 
PN, comprising approximately 1400 components in a mammalian cell (Balchin, Hayer-Hartl 
et al. 2016), is robustly organised and disruptions in the PN is strongly associated with 
diseases (Balchin, Hayer-Hartl et al. 2016). Moreover, many components of the PN decline 
during aging, and collapse of the proteostasis has been described as a primary hallmark of 
aging (Taylor and Dillin 2011, López-Otín, Blasco et al. 2013).  
 
1.2.1 Protein quality control by ribosomes and molecular 
chaperones 
 
In order to perform their normal function, most proteins need to be folded in their native 
three-dimensional form. Although small proteins of ~100 aa refold spontaneously in vitro, 
larger proteins require further assistance in order to find their correct folding (Balchin, Hayer-
Hartl et al. 2016). The folding process is an error-prone process, due to the large number of 
possibilities how a polypeptide chain could fold (Balchin, Hayer-Hartl et al. 2016). Although 
folding is opposed by entropy, there are many forces including hydrophobic forces, hydrogen 
bonding and intramolecular interaction which favour folding into the native state (Powers and 
Balch 2013). It should be noted, however, that proteins often need to be assisted in 
overcoming kinetic barriers, until they reach this thermodynamically favourable native state 
(Balchin, Hayer-Hartl et al. 2016).  
 
The native structure of proteins is constantly challenged, even by minor fluctuations in 
the environment such as pH or ionic strength. Moreover, a cell is not only confronted with the 
synthesis and folding of normal proteins, but also refolding, degradation or sequestration of 
misfolded, mutant or aberrant polypeptides. This challenge is even greater under stress 
conditions, pathology or aging (Chen, Retzlaff et al. 2011). Misfolded proteins can gain new 
functions which could be deleterious to the cell, or form toxic protein aggregates which will 
interact with many cellular compartments, overwhelm the proteostasis machinery and lead to 
pathology (Chen, Retzlaff et al. 2011). Aggregation of proteins is mainly caused by exposure 
of hydrophobic residues of a misfolded polypeptide backbone to the solvent in high 
concentration (Balchin, Hayer-Hartl et al. 2016).  Conformational diseases, which include but 
are not limited to age-associated neurodegenerative disorders such as Alzheimer’ (AD), 
Huntington’ (HD) or Parkinson’ (PD) diseases are caused by accumulation of misfolded 
proteins or metastable protein species such as amyloid fibrils (Chen, Retzlaff et al. 2011). 
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Thus, it is crucial for the cell to actively control and enhance the folding of proteins in order 
to survive.  
 
Poteostasis begins with the folding of proteins or preventing their misfolding, 
simultaneously with the biosynthesis of polypeptide chains (Wolff, Weissman et al. 2014). 
Different mechanisms are employed at the ribosome to increase translation fidelity. 
Modification of the translation rate, by using alternative codons for instance, could provide 
more time for chaperone binding, or inversely, prevent aggregation formation by decreasing 
the probability of intermediate folding (Wolff, Weissman et al. 2014). Additionally, 
proofreading mechanisms in the tRNA and co-translational folding by ribosome binding 
chaperones provide further possibilities for reaching the native state (Guo and Schimmel 
2013, Gloge, Becker et al. 2014).  
 
Molecular chaperones and folding factors that influence their ATPase activity and 
determine the folding pathway (Chen, Retzlaff et al. 2011) are the central hub of protein 
folding. Chaperones constantly detect abnormalities in protein conformation or function 
(Powers and Balch 2013, Brandvold and Morimoto 2015). They also assist proteins in their 
trafficking, refold denatured proteins or target irreparable misfolded proteins for degradation 
(Chen, Retzlaff et al. 2011, Labbadia and Morimoto 2015). Many of the chaperones are heat 
shock proteins (HSPs), which are highly expressed upon exposure conformational stresses. 
Based on their molecular weight, HSPs are divided in six groups: sHSP, HSP40, HSP60 
(chaperonins), HSP70, HSP90, and HSP100 (Brandvold and Morimoto 2015). However, not 
all the chaperones are induced by stress, and based on their functional clustering it has been 
suggested that they could be categorized in another distinct group: chaperones linked to 
protein synthesis (CLIPS) (Albanèse, Yam et al. 2006). The first chaperones to interact with 
the nascent polypeptide chain are ribosome-binding chaperones, which form two complexes: 
ribosome associated complex (RAC) and nascent chain associated complex (NAC) (Figure 
II). (Balchin, Hayer-Hartl et al. 2016). RAC and NAC bind the ribosome and the short 
nascent chains of the polypeptide, and couple co-translational folding with peptide elongation 
(Balchin, Hayer-Hartl et al. 2016). If the protein is unable to fold at the ribosome, the folding 
process is then continued with the action of chaperones with no interaction with the ribosome, 
such as Hsp70/Hsp40 system. Multiple Hsp70 chaperones or the hexameric prefoldin could 
act as intermediate so that the polypeptide is transferred to Hsp90 or chaperonin systems 
without formation of aggregation prone intermediates (Figure II). The folding process is then 
 13 
finalized either by the Hsp70, the chaperonin or the Hsp90 systems (Figure II). (Balchin, 
Hayer-Hartl et al. 2016). The two most abundant chaperone families, Hsp70 and Hsp90 are 
ATP dependant chaperones, could make up to 2% of the protein content of some cells, and 
have organelle specific homologs which are essential for the function of the endoplasmic 
reticulum (ER) (BiP and GRP94) or mitochondria (Mortalin and TRAP1) (Labbadia and 
Morimoto 2015). Co-chaperones (such as members of the DNAJ family) enhance the folding 
process by either stimulating the ATPase activity of the chaperone, or by delivering the 
misfolded proteins to the chaperones (Labbadia and Morimoto 2015). Another family of 
chaperones are the small heat shock proteins (sHSPs), which play an essential role in 
prevention of aggregation formation by forming homo-oligomeric structures which inhibits 
formation of molecular interactions which could lead to aggregation formation in the cytosol 
(Labbadia and Morimoto 2015). 
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Figure II. The mechanism of protein folding in Eukaryotic cells. The majority of polypeptides 
(~70%) are folded upon translation. The proteins unable to fold by ribosome associated chaperones 
are either folded by the orchestrated action of Hsp70/Hsp90 chaperones (~20%) or the chaperonin 
(~10%). Image has been modified from (Balchin, Hayer-Hartl et al. 2016), with permission from 
AAAS. 
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1.2.1.1  CCT/ TRiC is a central protein folding and disaggregation machine 
 
Almost 10% of the proteome could not be folded by the Hsp70/Hsp40 or Hsp90 
systems, and require the specialized function of the Hsp60/chaperonin family to reach their 
native state (Labbadia and Morimoto 2015). Chaperonins are highly conserved and are 
essential in all domains of life (Balchin, Hayer-Hartl et al. 2016). All chaperonins form 
multimeric cylindrical complexes to provide a protected cavity, in which a single molecule of 
non-native protein can be folded (Labbadia and Morimoto 2015, Balchin, Hayer-Hartl et al. 
2016). This family of molecular chaperones can be divided in two distinct groups. Group I 
chaperonins are present in bacteria (GroEL) and eukaryotic organelles derived from 
endosymbiosis: mitochondria (Hsp60) and chloroplasts (Cpn60) (Lopez, Dalton et al. 2015). 
Group II chaperonin, also known as class II TCP-1 Ring Complex (TRiC) or cytosolic 
chaperonin-containing t-complex polypeptide 1 (hereafter CCT), is found in the cytosol of 
eukaryotic cells. Both classes of chaperonins share similar structural characteristics forming a 
~1MDa complex consisting of two back-to-back rings, each containing seven to nine subunits 
of ~60 kDa (Labbadia and Morimoto 2015). CCT is responsible for the folding of many 
essential proteins, including components of the cytoskeleton such as actin and tubulin or cell 
cycle regulators (Lopez, Dalton et al. 2015). All CCT subunits share a common domain 
structure: an equatorial domain contains inter- intra-ring contacts as well as the ATP binding 
site, an apical domain which harbours the substrate binding domain and the intermediate 
domain which serves as a link between the two other domains (Yébenes, Mesa et al. 2011). 
Subunit arrangement in the complex is defined by their ATP binding affinity and charge 
(Reissmann, Joachimiak et al. 2012). Each subunit of the CCT complex has a different affinity 
for ATP, and alternating distribution of subunits with high and low affinity for ATP leads to 
sequential action of the complex (Balchin, Hayer-Hartl et al. 2016). CCT cycles between open 
and closed states (Figure III). Upon binding of ATP, the complex forms the closed 
conformation, and the state of bound nucleotide is communicated across all the subunits of the 
complex. Each subunit has helical protrusions that together form an iris-like lid (Balchin, 
Hayer-Hartl et al. 2016). Even in the closed state, the folding cavity is not perfectly sealed as 
the lid provides a small pore that can accommodate polypeptide chains facilitating the binding 
of large substrates in a domain-wise or co-translational fashion (Balchin, Hayer-Hartl et al. 
2016). Upon ATP hydrolysis, which is sensed by a conserved lysine residue, the lid of the 
complex forms a β-barrel to cover the folding chamber (Lopez, Dalton et al. 2015). Once ADP  
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is released from the active site, the lid goes into the open conformation again and the cycle 
continues. The hetero-oligomeric nature of this complex generates the functional asymmetry 
which is crucial for the folding of some specific substrates, which are unable to fold by any 
other chaperone system (Lopez, Dalton et al. 2015). Taken the large number of important 
subunits, it is clear that dysregulation of CCT is associated with a myriad of diseases including 
cancer and neuropathy. CCT is responsible for folding of proteins with complex topology 
(Yam, Xia et al. 2008) and ameliorates the cytotoxicity by changing  the aggregation state in 
models of HD and AD (Tam, Geller et al. 2006, Khabirova, Moloney et al. 2014). 
 
 
 
Figure III. Structural conformation and molecular mechanism of CCT/TRiC function. (a). 
Structure of the eukaryotic chaperonin TRiC (b). Mechanism of TRiC function. The subunit orientation 
of the TRiC complex is shown schematically as a top view of the ring. Nonnative substrate protein 
binds in a distinct topology contacting the apical domains of specific subunits (left). Upon ATP 
binding, TRiC releases the protein in a sequential manner aided by asymmetry in ATP affinities of the 
TRiC subunits (middle). After release, the protein folds to completion inside the TRiC cage, the 
hemispheres of which are partitioned into acidic and basic character. Image has been modified from 
(Balchin, Hayer-Hartl et al. 2016), with permission from AAAS. 
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1.2.2 Protein clearance mechanisms are essential for cell survival 
and are implicated in aging 
 
    1.2.2.1   The proteasome is the primary protein degradation machine in the cell 
 
In order to maintain protein homeostasis, it is absolutely essential that damaged or old 
proteins be degraded, so that the risk of aggregation is diminished and the amino acids could 
be recycled for new rounds of biosynthesis. The two main cellular proteolytic systems are the 
ubiquitin proteasome system (UPS) and autophagy. The UPS is the primary selective 
mechanism of protein degradation in eukaryotic cells (Schmidt and Finley 2014). The UPS is 
a carefully timed and precise mechanism which is critical for maintaining the appropriate 
levels of many regulatory proteins involved in several pathways such as signal transduction, 
metabolism or cell cycle (Finley 2009, Wong and Cuervo 2010, Buckley, Aranda-Orgilles et 
al. 2012, Okita and Nakayama 2012, Vilchez, Morantte et al. 2012, Tanaka and Matsuda 
2014). The UPS is not only necessary to degrade regulatory proteins but it is also an essential 
component of the proteostasis network necessary for eliminating damaged, misfolded and 
aggregation-prone proteins (Finley 2009, Wong and Cuervo 2010, Tanaka and Matsuda 
2014). The first step of the UPS-mediated proteolysis is the covalent conjugation of a highly 
conserved small protein, ubiquitin, through a sequential mechanism that targets proteins for 
degradation. The polyubiquitylated proteins are then recognized, unfolded and finally cleaved 
into small peptides by the proteasome (Vilchez, Saez et al. 2014) (Figure IV). The proteasome 
is a complex proteolytic machine of 2.5 MDa formed by the assembly of several subunits 
(Coux, Tanaka et al. 1996). The core particle (20S) of the proteasome consists of 28 subunits, 
which are assembled into four seven-membered rings and exhibit a barrel-like structure 
(Coux, Tanaka et al. 1996) (Figure IV). The two outer rings are composed by seven a-
subunits (named a1-a7), while the two inner rings are composed by seven b-subunits (b1-b7). 
b-rings contain the proteolytic active sites: b1, b2 and b5 present caspase-like, trypsin-like 
and chymotrypsin-like activities, respectively (Vilchez, Saez et al. 2014). Although 20S 
particles can exist in a free form, they are considered to be inactive due to its closed form and 
binding to proteasome activators is required for degradation of polyubiquitylated proteins 
(Kisselev and Goldberg 2005). However, free 20S particles can degrade small proteins in an 
ATP- and ubiquitination-independent manner (Baugh, Viktorova et al. 2009). The most 
common active proteasome results from the assembly of the 20S and the 19S (26S, single 
capped or 30S, double capped) (Finley 2009). The 19S regulates the activity of the complex 
and is responsible for recognizing, unfolding and translocating the polyubiquitylated proteins  
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Figure IV. The UPS is one of the main protein degradation systems in the cell. Proteins targeted 
for proteasomal degradation are tagged as the result of orchestrated action of E1, E2 and E3 enzymes. 
The ubiquitinated protein is either transferred to the proteasome by external factor, or interacts directly 
with ubiquitin receptors of the proteasome. The protein is then unfolded, ubiquitin moieties are 
removed by deubiquitinating enzymes, and pulled into the catalytic chamber to be cleaved into short 
peptides. Depending on the 20S activator, the UPS is also capable of degrading unubiquitinated or 
unstructured polypeptide chains. The wide range of UPS substrates are implicated in almost all 
important cellular processes. Image reprinted from (Vilchez, Saez et al. 2014), with permission from 
Nature Publishing Group. 
 
to the 20S for degradation.in an ATP dependent manner (Finley 2009, Tanaka and Matsuda 
2014). Notably, proteins and even protein aggregates can also be degraded in an ubiquitin-
independent way by free 20S or by 20S particles activated by other regulatory particles such 
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as PA28 or PSME4 (also known as the proteasome activator 200, PA200) (Dubiel, Pratt et al. 
1992, Ma, Slaughter et al. 1992, García-Mata, Bebök et al. 1999, Baugh, Viktorova et al. 
2009). PSME4 is a monomeric protein of 250 kDa and in contrast to the 19S regulatory 
particle; can activate the core proteasome without having ATPase or ubiquitin binding 
properties. PSME4 can form hybrid complexes in which this protein binds to one end of the 
20S proteasome and the 19S to the opposite end. PSME4 has been suggested to be essential 
for spermatogenesis and DNA repair, but the precise biological functions remain controversial 
and poorly understood.  
 
1.2.2.2 Autophagy: the bulk degradation pathway 
 
Parallel to the proteasome, autophagy is the main cellular protein clearance pathway. 
Although the UPS is considered to be the main protein degradation system in the cell, it is 
unable to degrade large protein complexes or aggregates (Labbadia and Morimoto 2015). 
Cytosolic fractions, organelles and macromolecules can be degraded by autophagy through 
the lysosome. Depending on cargo recognition system and the compartment it is delivered to, 
autophagy could be sorted in different categories. Macroautophagy is defined as engulfment 
of organelles or cytosolic regions by a double membrane structure known as autophagosome, 
which then fuses with the lysosome leading to degradation of its contents (Wong and Cuervo 
2010, Labbadia and Morimoto 2015). Microautophagy is defined as parts of the cytosol is 
directly sequestered by the lysosome, and chaperone mediated autophagy (CMA) which 
occurs through direct delivery of target proteins by a chaperone such as Hsc70 to the 
lysosome. These distinct forms of autophagy were initially believed to be induced upon stress, 
but recent evidence suggest a constitutive basal autophagic activity in most cell types (Wong 
and Cuervo 2010). Also in energy-demanding situations, such as nutrient-deprivation, 
autophagy degrades many different substrates to fulfil the energetic requirements of the cell 
(Egan, Kim et al. 2011, Rubinsztein, Mariño et al. 2011). These substrates include 
macromolecules that provide energy and nutrients during starving periods (Ravikumar, Sarkar 
et al. 2010). Moreover, due to its capacity to engulf whole cellular regions, autophagy is 
essential in processes that require extensive cellular restructuration, such as embryogenesis, 
cellular differentiation or cellular death (Cuervo 2004, Mizushima, Levine et al. 2008). The 
catalytic components of autophagy are the lysosomes. Lysosomes contain a large variety of 
cellular hydrolases, proteases, lipases, nucleotidases and glycosidases that show highest 
activity at acidic pH. Autophagy is required for maintaining cellular homeostasis, acting as a 
quality control mechanism of proteins and organelles. Moreover, lysosomal proteolysis results 
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in small di- and tripeptides and free amino acids that are released into the cytosol to be further 
metabolized to obtain energy or recycled to synthesize the novo proteins (Ravikumar, Sarkar 
et al. 2010, Mizushima and Komatsu 2011).  
 
1.2.2.3 Stress response pathways are a safeguard against proteotoxicity 
 
The PN is a very dynamic network and has been evolved to be able to protect the cell 
against proteotoxic stresses that cause protein misfolding, such as temperature shift or 
inflammation. Under such conditions, cells exhibit the capability of rapidly altering their PN 
by increasing the levels of molecular chaperones, co-chaperones and proteasomal subunits, to 
meet the transient necessity of responding to the proteostatic burden (Labbadia and Morimoto 
2015). For instance, the expression of HSP70 increases up to 20,000 fold at the transcript 
level in most cases of heat shock (Powers and Balch 2013) This rapid, stress-induced 
alterations in the PN include a global heat shock response (HSR) and unfolded protein 
responses (UPR) in the ER (UPRER) and mitochondria (UPRmt) of eukaryotic cells (Powers 
and Balch 2013).  
 
The HSR relies mainly on the action of sensitive heat shock transcription factors (HSF), 
that are maintained in an inactive state, for instance in a complex with a chaperone such as 
HSP90 or HSP70 (Powers and Balch 2013, Labbadia and Morimoto 2015). HSF1, which is 
considered to be the master regulator of HSR, for instance, is released from the chaperone 
upon protein denaturing stress, acquires DNA binding ability through homotrimerization and 
translocates to the nucleus in order to induce the transcription of many genes encoding 
molecular chaperones. When the stress is diminished, HSF1 activity is dampened by its 
acetylation, which again results in its binding to molecular chaperones (Labbadia and 
Morimoto 2015). Although distinct HSFs and pathways are involved, the same concept is 
relatively valid for HFSs responsible for activation of UPRER and UPRmt. These stress 
response pathways are essential for normal cellular physiology, as supported by the fact that 
HSF1 is essential for development in all domains of life (Labbadia and Morimoto 2015). 
Indeed, the importance of the proteome integrity is so high for multicellular organisms that 
proteotoxic stress is constantly monitored and signaled through the whole organism by 
complex mechanisms to ensure the optimal proteostasis both within (cell-autonomous) or 
between cells and tissues (cell-non autonomous) (Labbadia and Morimoto 2015). 
Downregulation of a mitochondrial complex IV subunit in neurons, for instance, can activate 
the UPRmt in the intestine of C. elegans, and enhance organismal longevity (Taylor, 
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Berendzen et al. 2014). Similar cell-non-autonomous mechanisms exist for HSR and UPRER, 
and the molecular nature of this phenomenon is beginning to be understood. Although the 
transient stress response increases the overall fitness of the cell or organism, tight regulation 
of these pathways is crucial for preventing the detrimental consequences of constitutive HSR, 
which is linked to multiple pathologies including many types of cancer (Labbadia and 
Morimoto 2015). 
 
1.2.2.4   Impaired proteostasis causes disease and contributes to aging  
 
Many human disorders can be categorized as PN disruptions. Amyloid fibrils are 
insoluble protein aggregates that are formed in the nucleus and cytoplasm of neurons. These 
inclusions are composed of large ordered fibrils of metastable β-sheet-enriched proteins that 
are believed to have a causative role in around 50 human diseases including HD, PD, AD 
(Labbadia and Morimoto 2015). Also, there is a consensus that the decline in the capacity of 
the proteostasis network is one of the main drivers of aging (Hartl 2016). In most cells and 
tissues aging is associated with extensive loss of proteostasis equilibrium, including 
widespread changes in translation, a generalized downregulation of chaperones, loss of 
function in protein degradation machineries and impaired UPR activation (Powers and Balch 
2013, Vilchez, Saez et al. 2014, Riera, Merkwirth et al. 2016). For instance, expression of 
almost one third of the chaperome network, including HSP40, HSP70, HSP90 and TRiC has 
been shown to decline during human brain aging (Labbadia and Morimoto 2015). Ultimately, 
this will result in accumulation of misfolded and aggregated proteins, which demolish cellular 
function due to their aberrant interactions with different cellular compartments (Hartl 2016). 
For instance, mutant huntingtin, tau or α-synuclein that underlie the pathology in HD, AD and 
PD respectively, has been shown to have an inhibitory effect on the protease activity on the 
26S proteasome (Wong and Cuervo 2010).  
 
Conversely, almost all signaling pathways that have been found to regulate longevity do 
so by modulating the proteostasis capacity (Hartl 2016). Reduction of insulin/IGF-1 signaling 
(IIS) is one of the most efficient means of lifespan extension and has been shown to be 
effective in both invertebrates and vertebrates (López-Otín, Blasco et al. 2013, Vilchez, Saez 
et al. 2014). Reduced IIS signaling activates the FOXO transcription factors by altering the 
phosphorylation state, so that the activated transcription factor can translocate to the nucleus 
and regulate the expression of genes that extend lifespan (Vilchez, Saez et al. 2014). The 
longevity extension by reduction in IIS in C. elegans is dependent on HSF-1 and an E3 
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ubiquitin ligase complex CUL-1 and suppresses age dependent aggregation and toxicity in 
worm models of HD and AD (Labbadia and Morimoto 2015, Hartl 2016). HSF1A, which 
activates HSF1 by reducing CCT activity and blocking the interaction between CCT and 
HSF1 has been shown to suppress toxicity in cellular models of HD (Labbadia and Morimoto 
2015). 
 Moreover, autophagy has been demonstrated to be essential for the lifespan extension 
observed in all the long lived C. elegans strains (Vilchez, Saez et al. 2014). In addition, 
various lines of research provide examples of improving proteostasis by means of genetic 
manipulation that are enough to delay aging and decrease the incidence of age-associated 
pathologies in model organisms including mammalian systems (Zhang and Cuervo 2008). For 
instance, upregulation of autophagy has been demonstrated to ameliorate the protein toxicity 
in HD models of neurodegeneration (Chen, Retzlaff et al. 2011) and overexpression of 
chaperones extends lifespan in different model organisms (López-Otín, Blasco et al. 2013). 
Similarly, ectopic induction of UPS, UPRER or UPRmt activity has been shown to prevent age-
related decline of proteostasis and delay the onset of pathologies (Vilchez, Morantte et al. 
2012, Powers and Balch 2013). Apart from genetic manipulation, regulation of PN by means 
of small molecules has been proven to be successful. Spermidine, an autophagy activator 
which in contrast to other autophagy inducers such as rapamycin does not have 
immunosuppressive side effects, has been shown to extend lifespan in yeast, flies and worms 
(López-Otín, Blasco et al. 2013).  
 
Together, an increasing number of experiments suggest that targeting the PN by means 
of genetic manipulation or small molecules could hold a great promise for developing new 
therapies against aging and age-associated diseases.  
 
1.3 Stem cells and stem cell proteostasis in aging  
 
1.3.1 Stem cells are pluripotent and self-renewing 
 
Stem cells are generally characterized by their pluripotency, the capability to 
differentiate into more specialized cells, and their self-renewal capacity (Schilders, Eenjes et 
al. 2016). A distinction can be made between embryonic stem cells (ESCs), induced 
pluripotent stem cells (iPSCs) and adult stem cells. ESCs are derived from the inner cell mass 
(ICM) of a blastocyst, a structure formed after multiple mitotic cell divisions of the zygote 
(Vazin and Freed 2010). A blastocyst consists of two cellular layers: the outer layer, also 
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known as trophoblast forms the extra-embryonic tissues such as the placenta, chorion and the 
umbilical cord (Vazin and Freed 2010). The ICM contains all the cells, which will give rise to 
the embryo, and the primitive endoderm (Nishikawa, Jakt et al. 2007, Vazin and Freed 2010). 
ESCs can be obtained from ICM under specific culture conditions, and possess the ability to 
differentiate into ectodermal, mesodermal and endodermal lineages (Nishikawa, Jakt et al. 
2007, Schilders, Eenjes et al. 2016).  
 
ESCs can maintain their pluripotency and functional confirmation of this characteristic 
can be achieved by analysis of expression levels of genetic markers of pluripotency or 
different germ layers, or formation of teratoma in vivo (Vazin and Freed 2010). Their 
capability of resuming development once seeded back into the blastocyst has made ESCs a 
popular tool as a vehicle to introduce genetic manipulations in model organisms (Martello and 
Smith 2014).  
 
Although ESCs might acquire chromosomal aberrations due to prolonged maintenance 
in vitro, they do not undergo senescence and exhibit an indefinite proliferative lifespan 
(Martello and Smith 2014). This great self-renewal capacity, together with their 
differentiation potential makes ESCs a valuable tool for studying embryogenesis and 
development, as well as disease modelling, drug discovery and regenerative medicine 
(Nishikawa, Jakt et al. 2007, Schilders, Eenjes et al. 2016). This is particularly important for 
studying human biology, where availability of tissue sample is extremely limited. There are, 
however, ethical issues that can hamper the use of ESCs because these cells are derived from 
embryos produced by in vitro fertilization for clinical purposes. Immune incompatibility is the 
other constraint for using ESCs in regenerative medicine.  
 
The ground breaking discovery that differentiated cells can be reprogrammed to 
pluripotent state resulting to formation of induced pluripotent stem cells (iPSCs) by 
expression of four transcription factors OCT4, SOX2, KLF4 and MYC (Takahashi and 
Yamanaka 2006) was a major step forward in using the promising potential of stem cells. 
iPSCs resemble ESCs in different aspects of their biology from morphology, regulation of 
signaling pathways and the capability to differentiate towards all the three primary germ 
layers, as well as forming teratomas in vivo (Medvedev, Shevchenko et al. 2010). Strikingly, 
iPSCs created from adult somatic cells were shown to be able to develop to viable, fertile 
organisms in mice (Zhao, Li et al. 2009, Zhao, Li et al. 2010). The process of reprogramming, 
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however, is just beginning to be understood. There are many methods for inducing 
pluripotency, and it seems that not all the abovementioned transcription factors are essential 
for reprogramming of all cell lines. For instance, fibroblasts have been shown to be able to 
reprogram without expression of MYC, or neural stem cells only require OCT4 expression to 
be reprogrammed (Jopling, Boue et al. 2011). Moreover, the efficiency of the process is still 
very low, and it takes a substantial period of time to induce pluripotency (Jopling, Boue et al. 
2011). There are also different studies which suggest that reprogramming process 
demonstrates significant variability, which leads to aberrant epigenomic reprogramming, 
which can result in different gene expression signatures compared to ESCs (Chin, Mason et 
al. 2009, Lister, Pelizzola et al. 2011). Taken together, although iPSCs provide a great 
potential to be used as a tool for understanding development and disease, a much deeper 
understanding of iPSC biology is necessary before application of ESCs could be wholly 
substituted with iPSCs.  
 
1.3.2 Stem cell exhaustion contributes to organismal aging 
 
Beside ESCs and iPSCs, adult stem cells are a group of stem cells, which reside in 
different tissues throughout the lifetime, and are responsible for the repair and regeneration in 
that tissue. In human body, these include hematopoietic stem cells (HSCs), intestinal stem 
cells, mammary stem cells, olfactory stem cells, mesenchymal stem cells, endothelial stem 
cells and neural stem cells. Adult stem cells are capable of differentiating into multiple cell 
types of a tissue, but exhibit a lower level of pluripotency and self-renewal compared to ESCs 
(Schilders, Eenjes et al. 2016). There is a consensus that stem cell exhaustion, which underlies 
the decline in regenerative potential of tissues, is one of the main drivers of aging (Ho, 
Wagner et al. 2005, López-Otín, Blasco et al. 2013). Signs of aging could be detected in stem 
cells of different tissues such as hematopoietic stem cells, intestinal stem cells, satellite cells, 
neural or skin stem cells (Schultz and Sinclair 2016). This phenotypes are mainly considered 
to be a result of accumulated DNA damage, cell cycle dysregulation and telomere shortening 
(López-Otín, Blasco et al. 2013). Additionally, as stem cells rely on the signals from the 
environment, or niche, aging of the niche or inflammation can also interfere with the cellular 
communication and thus impair stem cell function (Schultz and Sinclair 2016). 
 
As any damage in the stem cells could influence the resulting lineage of cells, this 
accumulation of damage in stem cells is potentially more harmful for the organism.  In order 
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to counteract the detrimental consequences, stem cells use different strategies such as 
asymmetric segregation of damaged cellular components and enhanced proteostasis. Stem 
cells have the capacity of undergoing two kinds of cell divisions: symmetric division leads to 
production of two daughter cells with equivalent biology, whereas asymmetric division 
produces a daughter cell and a differentiating cell (Martello and Smith 2014). Similar to 
budding yeast, stem cells asymmetrically segregate damaged organelles and proteins to the 
differentiating cell, so that the daughter stem cell, which will presumably last longer can be 
kept in a young state (Schultz and Sinclair 2016). This damage clearance is so essential for 
the function of stem cells, that if disrupted, it can lead to complete loss of stem cell properties 
in the progeny cells (Katajisto, Döhla et al. 2015). 
 
1.3.3 Adopting stem cell proteostasis as a novel paradigm for 
developing therapies against aging and age-related diseases 
 
Stem cells, as described above, demonstrate striking differences in their biology 
compared to somatic cells. One of the major differences is at the level of proteostasis 
mechanisms. Components of the chaperome network, for instance, are differentially regulated 
in stem cells. At the transcript level, 119 genes were found to be downregulated and 44 genes 
were upregulated during differentiation of hESCs to neural progenitor cells (NPCs). At the 
protein level, 36 out of 122 identified chaperome components decrease during differentiation 
of hESCs into NPCs. In contrast, 27 chaperome components were increased during neural 
differentiation (Noormohammadi, Khodakarami et al. 2016). Some of the HSPs seem to have 
specialized functions in stem cells, which makes them indispensable for stemness. For 
instance, HSP90 interacts with OCT4 and NANOG and protects them from degradation by 
the UPS and downregulation of HSP90 leads to differentiation of mESCS (Vilchez, Simic et 
al. 2014). 
 
It has been shown that mouse and human ESCs exhibit higher proteasome activity 
compared to their differentiated counterparts such as neurons, fibroblasts and trophoblasts 
(Vilchez, Boyer et al. 2012). This increased proteasome activity is essential for stem cell 
pluripotency and reprogramming, and is dependent on higher levels of the 19S proteasome 
subunit PSMD11, which in turn stabilizes the interaction of the 20S and 19S. Other 
proteasome subunits such as α2–α5 and the immunoproteasome subunits β1i and β5i are also 
increased in hESCs (Vilchez, Saez et al. 2014). Interestingly, mESCs induce the proteasome 
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activator PA28 to degrade damaged proteins upon initiation of differentiation and cell fate 
decision (Hernebring, Brolén et al. 2006).  
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Figure V. Proteostasis of stem cells. Proteostasis in stem cells. (A) Embryonic stem cells (ESCs) 
exhibit increased levels of heat-shock protein (HSPs) and 26S/30S proteasome activity and are more 
protected from reactive oxygen species (ROS) than their differentiated counterparts. In an active 
rejuvenation step, both autophagy and the immunoproteasome activities increase during the first days of 
differentiation. HSPs, autophagy, and the ubiquitin–proteasome system (UPS) are required to maintain 
ESC features such as self-renewal and pluripotency. HSPs and the UPS are required for differentiation 
of ESCs into specific cellular lineages. (B) Hematopoietic stem cells (HSCs) exhibit increased levels of 
autophagy activity compared with their differentiated counterparts. Low levels of ROS and increased 
levels of HSPs and autophagy activity are required to maintain HSC self-renewal. HSPs are required for 
differentiation of HSCs. (C) Dietary restriction (DR) improves muscle satellite cell self-renewal. HSPs 
are required for differentiation of muscle satellite cells. (D) DR and increased levels of HSPs improve 
intestinal stem cell (ISC) self-renewal. Endoplasmic reticulum (ER) stress and HSPs affect 
differentiation of ISCs. Image reprinted from (Vilchez, Simic et al. 2014), with permission from 
Elsevier.  
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Moreover, different stem cells such as human mesenchymal stem cells (hMSCs), 
HSCs, dermal and epidermal stem cells and iPSCs have been shown to have increased 
autophagy compared to differentiated cells, and HSCs and hMSCs were shown to be 
dependent on autophagy for maintaining pluripotency and proliferation (Salemi, Yousefi et al. 
2012, Signer and Morrison 2013). Conversely, upon differentiation of neural or cardiac stem 
cells, autophagy increases and blocking autophagy impairs their differentiation (Vázquez, 
Arroba et al. 2012, Zhang, Liu et al. 2012) 
 
Apart from protein clearance mechanisms, hESCs were shown to accumulate less 
ROS, presumably due to higher antioxidant defence mechanisms such as 
glutathione/thioredoxin system enzymes (Tgr, Gpx2/3/4, Gsta3, Prdx2, Pdh2), which are 
highly expressed in ESCs compared with their differentiated counterparts (Vilchez, Simic et 
al. 2014). The same is valid for components of stress response pathways such as UPRER. 
Components of this pathway such as IRE1, XBP1 and CHOP have been shown to have an 
important roles during differentiation (Vilchez, Simic et al. 2014). Additionally, ESCs not 
only exhibit accelerated proliferation rates, but also enhanced global translation rates 
compared to differentiated cells (You, Park et al. 2015, Lee, Gutierrez-Garcia et al. 2017). 
Decreasing translation rates by means of chemical inhibitors or genetic manipulation has been 
shown to affect pluripotency and reprogramming potential (You, Park et al. 2015). Thus, this 
enhanced proteostasis could be essential for stem cells in order to be able to cope with their 
higher metabolic demands. Taken together, although different types of stem cells exhibit 
differences in their proteostasis in different stages (Figure V) it seems that stem cells benefit 
from a unique proteostasis profile that helps them in responding fast to environmental stress 
and also provide the progeny cells with a healthy proteome.  
 
There is a growing body of evidence that proteostasis of stem cells could serve as a 
model for studying aging and associated pathologies. For instance, overexpression of rpn-6, 
the C. elegans orthologue of PSMD11, was enough to enhance worm survival under 
proteotoxic stress conditions (Vilchez, Morantte et al. 2012). This leads to the intriguing 
hypothesis that it might be possible to adopt mechanisms that underlie stem cell immortality, 
such as enhanced proteostasis, to improve aging associated phenotypes and pathologies at the 
organismal level. The increased proteasome activity and the longevity phenotype in the worm 
is modulated by DAF-16, the worm orthologue of FOXO transcription factors (Vilchez, 
Morantte et al. 2012). Strikingly, FOXO4 is necessary for the increased proteasome activity in 
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hESCs and their differentiation into neural lineages (Vilchez, Boyer et al. 2013). FOXO1 is 
also required for hESC pluripotency (Zhang, Yalcin et al. 2011). Thus, FOXO transcription 
factors seem to be a link between stem cell function and organismal longevity.  
 
Taken together, studying proteostasis of stem cells we will not only lead towards a 
deeper understanding of stem cell biology, but learning from this immortal units of life might 
provide a novel paradigm for development of new remedies against aging. 
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2 Material and methods 
 
2.1 Material  
 
Table 1 List of Cells, Bacteria and Worm strains  
 
 
Name 
 
Description 
 
Reference 
H9 (WA09) 
H1 (WA01) 
hFIB2-iPS4 
HD-iPSC#1 
ND42242 
ND36997 
ND41656 
ND36998 
ND42229 
ND36999 
GM02183 
GM03621 
GM04281 
GM09197 
ND30014 
ND33392 
DH5α 
DH10ß 
HT115 
N2 
CF512 
CB4037 
DA1116 
CF1041 
DVG9 
DVG20 
DVG22 
DVG41 
DVG44 
DVG47 
DVG48 
DVG49 
DVG50 
DVG55 
DVG57 
DVG58 
DVG59 
AM716 
hESC 
hESC 
HD iPSCs control 
HD iPSC Q71 
iPSC Q21 control 
iPSC Q33 control 
HD iPSC Q57 
HD iPSC Q60 
HD iPSC Q71 
HD iPSC Q180 
Fibroblast Q33 control 
Fibroblast Q60 
Fibroblast Q71 
Fibroblast Q180 
Fibroblast Q21 control 
Fibroblast Q57 
Chemocompetent E. coli 
Chemocompetent E. col 
RNAi strain 
Wild type C. elegans strain 
fer-15(b26)II;fem-1(hc17)IV 
glp-1(e2141) III 
eat-2(ad1116) II 
daf-2(e1370) III 
N2, ocbEx9[myo3p::gfp] 
N2,ocbEx20 [sur5p::C14C10.5, myo3p::gfp] 
N2,ocbEx22 [sur5p::C14C10.5, myo3p::gfp] 
N2, ocbEx41[psur5::cct-5 pmyo3::gfp] 
N2, ocbEx44[psur5::cct-7, pmyo3::GFP] 
N2, ocbEx47[psur5::cct-2, pmyo3::GFP] 
N2, ocbEx48[psur5::cct-8, pmyo3::GFP] 
N2, ocbEx49[psur5::cct-8, pmyo3::GFP] 
N2, ocbEx50[psur5::cct-2, pmyo3::GFP] 
AM716 x DVG9 
AM716 x DVG49 
N2, ocbEx55[psur5::cct-5, pmyo3::GFP] 
AM716 x DVG50 
(rmIs284[pF25B3.3::Q67::YFP] 
WiCell Research Institute 
WiCell Research Institute 
(Park, Zhao et al. 2008) 
(Park, Arora et al. 2008) 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
Coriell Institute 
RUDCR infinite biologics 
RUDCR infinite biologics 
Thermo Fisher Scientific 
Thermo Fisher Scientific 
CGC 
CGC 
CG    CGC 
CGC 
CGC 
Kenyon lab 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
Morimoto lab 
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Table 2 List of chemicals 
 
Name 
 
Reference 
2-Mercaptoethanol 
2-Propanol 
5-Bromo-2`Deoxyuridine 
Aceton 
Adenosine 5′-triphosphate disodium salt hydrate 
Albumine from Bovine Serum 
Ammonium Bicarbonate  
Ammoniumsulfate 
Aprotinin From Bovine Lung  
Bacto Yeast Extract 
Bacto-Tryptone 
Calcium Chloride Dihydrate 
Chloroform 
Cholesterol (Cholesterol) 94% 
Citric Acid 
Coomassie Brillantblau G-250  
Cycloheximide 
D-(+)-Galactose 
D-(+)-Glucose 
Deoxycholic Acid Sodium  
Dibutyryl Camp Sodium Salt  
Diethyl Pyrocarbonat 
Dimethl Pimelimidate Dihydrochloride 
Dl-Dithiothreitol 
DMSO 
EDTA 
Edta Solution Ph 8,0 
Ethanol 99,5% (Denat. 1% Mek) 
Ethanol Pure 
Ethanolamine Free Base 
Formaldehyde, 10%, Methanol Free 
Gelatin From Porcine Skin 
Glacial Acetic Acid 
Glycerol, 500 Ml 
Glycin  
Hepes Steril 1M Ph7.3 
Hydrochloric Acid 
Hydrogen Peroxide 30% 
Igepal Ca-630 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Carl Roth 
Sigma 
BD 
BD 
Sigma 
Sigma 
Sigma 
Sigma 
VWR 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
VWR 
VWR 
Sigma 
Sigma 
Polyscience 
Sigma 
Sigma 
LifeTechnologies 
Sigma 
VWR 
Sigma 
Sigma 
Sigma 
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Isopropanol 
Kaliumhydrogenphospat 
Kanamycin Sulfate 
L-Ascorbic Acid, 
L-Ascorbic Acid, Reagent Grade 
LB Broth 
Magnesium Chloride Hexahydrate 
Methanol   
Methylviologen Hydrat 98% (Paraquat) 
Mops 
Mowiol 
N-Acetyl-L-Cysteine  
N-Ethylmaleimide 
N,N-Dimethylformamid  
Nonfat-Dried Milk From Bovine  
Peptone 
Phenol Chloroform 
Phenylmethylsulfonyl  fluoride (PMSF) 
Poly-L-Ornithine Hydrobromide 
Ponceau S Solution 
Potassium Acetate 
Potassium Chloride 
Potassium Dihydrogen Phosphate 
Potassium Hydrogen Phosphate Dibasic  
Potassium Hydroxide 
Proteinase K, Recombinant 
Rnasezap 
Rubidium Chloride 
SDS- sodium dodecyl sulfate 
Sodium 4-Phenylbutyrate 
Sodium Acetate, Anhydrous 
Sodium Azide  
Sodium Azide  
Sodium Chloride 
Sodium Fluoride 
Sodium Hydrogen Phosphate Dibasic 
Sodium Hypochlorite Solution  
Sodium Orthovanadate  
Sodium Selenite  
Sucrose  
Terrific Broth  
Tetracycline Hydrochloride 
Thapsigargin 
Transferin, Human, Recombinant 
Sigma 
Roth 
LifeTechnologies 
Sigma 
Sigma 
Merck 
Millipore 
Sigma 
VWR 
Sigma 
Carl Roth 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
BD 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Fisher 
ALFA 
ALFA 
Sigma 
Roche 
Sigma 
Sigma 
Sigma 
VWR 
Sigma 
Sigma 
VWR 
Sigma 
Sigma 
ALFA 
Sigma 
Sigma 
Sigma 
Sigma 
VWR 
Sigma 
Sigma 
Sigma 
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Table 3 List of culture media and chemicals 
Trichloroacetic Acid 
Tris 1M Ph 7,5  
Triton X-100 
Trizma Base 
Trypan Blue Solution (0,4%) 
Tunicamycin 
Tween® 20  
 
Sigma 
VWR 
Sigma 
Sigma 
Sigma 
Sigma 
Biochemica 
 
  
 
Name 
 
Source 
10X dPBS   
10X Tris Buffered Saline 
10X Tris/Boric Acid/Edta 
10X Tris/Glycine 
10X Tris/Glycine/Sds 
1X Pbs, W/O Ca/Mg 
4X Laemmli Sample Buffer 
4X500Ml Acrylamide/Bis Solution 37,5:1 
Accutase 100 Ml 
Agar Agar  
Agarose, Ultrapure 500G 
Ammonium Persulfate, 10 G 
B27 Serumfree Supplement 
BDNF Human 
Carbenicillin, Disodium Salt  
Cf-1 Mefs 
Collagenase Type Iv 
Dapi (4,6 Diaminido-2-Phenylin)  
Depc-Treated Water  
Life technologies 
BioRad  
BioRad  
BioRad  
BioRad  
Life technologies 
BioRad  
Serva 
Life technologies 
Serva 
Life technologies 
BioRad  
Life technologies 
Peprotech 
Life technologies 
Amsbio 
Life technologies 
Life technologies 
Life technologies 
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Dispase 
Dmem  
Dmem, No Glucose 
Dmem/F-12, Hepes 
Dmem/F:12 
Epidermal Growth Factor  
Fbs South American Hi  
Fgf-Basic Human 1000µg 
Fluorsave Reagent 
GDNF Human 
Geltrex Ldev  
Gentle Cell Dissociation Reagent  
Glutamax 1 
Glycogen 
Hanks' Balanced Salt Solution 
Hoechst 
Incuwater-Clean  
Iptg (Dioxane Free) 50G 
Knockout Serum Replacement  
Laminin 
Non Essential Amino Acids 
Minimum Essential  Eagle Medium  
mTeSR1  
N2 Supplement  
Neurobasal Medium  
Nitrocellulose Membrane 45µm  
Optimem  
Pbs, W/O Ca/Mg (10X)  
Penicilin/Streptomycin  
Protease Inhibitor (25 Tabl.) 
Puromycin10X1Ml 
Rock Inhibitor (Y-27632 Dihydrochloride) 
SDS Solution 20% (w/v) 
Sodium Bicarbonate 
Stacking Gel Buffer 
Stemdiff Definitive Endoderm 
Stemdiff Neural Induction Medium  
Stemdiff Neural Progenitor Medium 
Trypsin 0.25 Edta 
Yeast Extract 
 
Stemcell Technologies 
Life technologies 
Life technologies 
Life technologies 
Life technologies 
Sigma 
Life technologies 
Peprotech 
Merck 
Peprotech 
Life technologies 
Stemcell Technologies 
Life technologies 
Life technologies 
Sigma 
LifeTechnologies 
VWR 
Promega 
Life technologies 
Life technologies 
Life technologies 
Sigma 
Stemcell Technologies 
Life technologies 
Life technologies 
Bio-Rad 
Life technologies 
Life technologies 
Life technologies 
Sigma 
Life technologies 
Abcam 
BioRad  
Life technologies 
BioRad  
Stemcell Technologies 
Stemcell Technologies 
Stemcell Technologies 
Life technologies 
BD 
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Table 4 List of chemicals and enzymes for molecular biology 
 
 
 
 
 
 
 
Name 
 
Source 
EcoRI-HF® 
NheI-HF® 
NotI-HF® 
XbaI 
XmaI 
Gibson Assemblytm Master Mix  
T4 Polynucleotide Kinase 
T4 Polynucleotide Kinase  
T4 Dna Ligase 
T4 Dna Ligase 
T7 Endonuclease I 
Dna Pol. Large Fragment 
T4 Rna Ligase 2, Truncated  
Mung Bean Nuclease  
Taq Dna Polymerase 
Exonuclease I  
Rnase H, Recombinant 
Dnase I (Rnase-Free) 
Quick Ligation Kit 
Deoxynucleotide Solutions, Mix 
Quick-Load® 1 Kb Dna Ladder 
Q5® High-Fidelity Dna Polymerase  
Onetaq® Dna Polymerase  
Peqgreen 
1Kb Plus Dna Ladder 250µg 
Blue/Orange Loading Dye 
Taq Polymerase 
Shrimp Alkaline Phosphatase 
Plasmid-Safe Dnase 
Serva Fastload 100bp DNA ladder 
Dnase I (Rnase-Free)  
Ribonucleoside-Vanadyl Complex 
Rnase Out Rnase Inhibitor 
Trizol Ls 200Ml 
Ultrapure Dnase/Rnase-Free Water 
 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
NEB 
Peqlab 
Fisher Scientific  
Promega 
VWR 
NEB 
Biozym 
Serva 
Fisher Scientific  
NEB 
LifeTechnologie 
Life technologies 
Life technologies 
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Table 5 List of Antibodies and chemicals for protein biochemistry 
 
 
 
 
 
 
 
 
 
 
Name 
 
Source 
  Anti-Polyglutamin 
Alexa Fluor 488 Goat anti Mouse IgG (H+L)  
Alexa Fluor 488 Goat anti Rabbit IgG (H+L)  
Alexa Fluor 546 Goat anti Mouse IgM 
Alexa Fluor 568 F(ab’)2 Fragment of Goat Anti-Rabbit IgG (H+L)  
Anit-Map2 
Anti-PSME4 
Anti-CCT6a 
Anti-CCT8 
Anti-ECM29 antibody 
Anti-Nanog 
Anti-TCP1 alpha 
Anti-TCP1B 
Anti-TCP1E 
HRP AP Donkey Anti-Mouse IgG (H+L) 
HRP AP Donkey Anti-Rabbit IgG (H+L)  
HRP AP Donkey Anti-Rat IgG (H+L)  
Stemdiff Neural Progenitor Antibodypanel 
Clarity Western ECL Substrate  
Hi-Mark Pre-Stained Proetin Ladder, 250µl 
Immobilon Western Chemilum Hrp Substrate 
PVDF.45Um Mmobilon 
Mini-Protean TGX 10%  
Precision Plus Protein Dual Color Standards, 5X500Μl 
Protein Assay Dye Reagent Concentrate, 450 Ml 
Resolving Gel Buffer, 1.5 M Tris-Hcl, Ph 8.8, 1 L 
Filter Trap Membrane 
Temed 
Tris 
 
 
 
 
  
    Proteintech 
Life technologies 
Life technologies 
Life technologies 
L fe technologies 
Sigma 
Abcam 
Abcam 
BioZol 
Abcam 
Stemcell technologies 
Abcam 
Abcam 
Abcam 
Jackson Immuno Research 
Jackson Immuno Research 
Jackson Immuno Research 
Stemcell Technologies 
BioRad  
Life technologies 
Merck 
Merck 
Bio-Rad 
BioRad  
BioRad  
BioRad  
VWR 
BioRad  
BioRad  
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Table 6 List of kits  
 
 
 
Table 7 List of plasmids  
 
 
 
 
 
 
 
Name 
 
Source 
Addgene FireLab Kit 
Fugene 
HiSpeed Plasmid Maxi Kit  
Normocin 
Pierce BCA Proetin Assay Kit 
Puerlink Mini Kit 
Qiagen LongRange 2Step RT-PCR Kit  
Qiagen Plasmid Plus Midi Kit 
Qiagen-tip 20 
QIAquick PCR purification Kit  
QIAzol Lysis Reagent  
Quanta Q Flex Reverse Transcription Kit  
RNA Bee  
SsoAdvanced SYBR Green Supermix 
StemTag Alkaline Phospate Staining Kit 
Zymoclean Gel DANN Recovery Kit 
 
Addgene 
Promega 
Quiagen 
InvivoGen 
Fisher Sientific 
Life Technologies 
Quiagen 
Quiagen 
Qiagen 
Quiagen 
Quiagen 
VWR 
Gentaur 
Bio-Rad 
BioCat 
Zymo 
 
 
Name 
 
Description 
 
Reference 
 
CCT8 ORF HA 
pDV032 
pDV066 
pDV061 
pDV064 
pDV067 
pDV068 
pDV077	
 
 
 
Mammalian CCT8 ORF 
Sur5p::C14C10.5 (PSME4 orthologue) 
Sur5p::T21B10.7.1 (CCT-2 orthologue) 
Sur5p::C07G2.3 (CCT-5 orthologue) 
Sur5p::T10B5.5 (CCT-7 orthologue) 
Sur5p::Y55F3AR.3a (CCT-8 orthologue) 
Sur5p::F01F1.8a.1 (CCT-6 orthologue) 
GFP under cct-8 promoter 
 
 
Sino Biological 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
 
 
 
 38 
 
Table 8 List of Lentivirus  
 
 
 
 
 
Table 9 List of primers used for molecular cloning 
 
 
 
 
 
 
Name 
 
Source 
 No-target Control (SHC016V-1EA) 
 PSME4 (TRCN00000158223) 
 PSME4 (TRCN00000152425) 
CCT2   (TRCN0000029499) 
CCT2   (TRCN0000029500) 
CCT6a (TRCN0000062514) 
CCT6a (TRCN0000062515) 
CCT7   (TRCN0000147373) 
CCT7   (TRCN0000149108) 
CCT8   (TRCN0000438803) 
CCT8   (TRCN0000442235) 
 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
 
 
 
Name 
 
Sequence (5´-3´) 
C14C10.5 NotI F 
C14C10.5 XbaI R 
T21B10.7.1 NheI F 
T21B10.7.1 NotI R 
C07G2.3a.1 NheI F 
C07G2.3a.1 NotI R 
F01F1.8a.1  NheI F 
F01F1.8a.1  NotI R 
T10B5.5a    NheI F 
T10B5.5a    NotI R 
Y55F3AR.3a    NheI F 
Y55F3AR.3a    EcoRI R 
Y55F3AR.3a promoter F XmaI 
Y55F3AR.3a promoter R XbaI 
 
TTGGCGGCCGCACTATCTTCCCATTGCAGTTATTTT 
CAATCTAGACCGAAAGGGTTGTGGGATGA 
TTGGCTAGCATGCTTCCAGTCCAAATTTTAAA 
CAAGCGGCCGCTTAGCATGGTCGGTTATCTTG 
TTGGCTAGCATGGCGCAGTCATCTGC 
 CCAGCGGCCGCTTAATATCCCATTCTTTCATCGTCA 
TTGGCTAGCATGTCGTCAATCCAGTGCCT 
CCAGCGGCCGCTTATTCTGGTTGTGGCTGCTTC 
TTGGCTAGCATGATGCGCCCACCAATTAT 
CAAGCGGCCGCTTATTGCCCGGGAAGTCCTG 
TTGGCTAGCATGGCTATGAAGATCCCAAAGTC 
CAAGAATTCTTAGGCCATTCCATCGTCATC 
TTGTCTAGATTAGGCCATTCCATCGTCATC 
TTGCCCGGGATGGCTATGAAGATCCCAAAGTC 
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Table 10 List of primers used for qPCR 
 
 
Name 
 
Forward  (5´-3´) 
 
Reverse  (5´-3´) 
ACTB 
GAPDH 
0CT4 
NANOG 
SOX2 
DPPA4 
DPPA2 
ZFP42 
AFP 
ALB 
CD117 
CXCR4 
GATA4 
GATA6 
PECAM 
SOX17 
FGF5 
NES 
PAX6 
VIM 
CDH2 
EOMES 
FOXF1 
MSX1 
GATA6 
SNAI2 
CCT2 
CCT5 
CCT6A 
CCT7 
CCT8 
 
CTGGCACCCAGCACAATG 
GCACCGTCAAGGCTGAGAAC 
GGAGGAAGCTGACAACAATGAAA 
AAATCTAAGAGGTGGCAGAAAAACA 
TGCGAGCGCTGCACAT 
CTGGTGCCAACAATTGAAGCT 
GTACTAATGGCAAGAAAATCGAAGTT 
CCTGCAGGCGGAAATAGAAC 
GAGGGAGCGGCTGACATTATT 
TGAGGTTGCTCATCGGTTTAAA 
CCAAGGCCGACAAAAGGA 
GGCCGACCTCCTCTTTGTC 
TCCGTGTCCCAGACGTTCTC 
AGCGCGTGCCTTCATCA 
GGAGTCCAGCCGCATATCC 
TGGCGCAGCAGAATCCA 
ACGAGGAGTTTTCAGCAACAAAT 
TGAAGGGCAATCACAACAGG 
CATACCAAGCGTGTCATCAATAAAC 
TCTGCCTCTTCCAAACTTTTCC 
CAGCAACGACGGGTTAGTCA 
ATGCAGGGCAACAAAATGTATG 
AGCCGTATCTGCACCAGAACA 
CTCCGCAAACACAAGACGAAC 
AGCGCGTGCCTTCATCA 
TGCGGCAAGGCGTTTT 
AAGCCACGAAGGCTGCAA 
CGGATAAGTGCCCCACCTTA 
TGGCCAGAACATCTCTTCGTACT 
GTGGCATGGACAAGCTTATTGTAG 
ACCCGGAGGTGGAGCAA 
 
CCGATCCACACGGAGTACTTG 
GGATCTCGCTCCTGGAAGATG 
GGCCTGCACGAGGGTTT 
GCCTTCTGCGTCACACCATT 
TCATGAGCGTCTTGGTTTTCC 
AGGCACACAGGCGCTTATATG 
GCCGTTGTTCAGGGTAAGCA 
GCACACATAGCCATCACATAAGG 
ACCAGGGTTTACTGGAGTCATTTC 
GCAATCAACACCAAGGCTTTG 
GGCGGGAGTCACATCTCTTTC 
TTGCCACGGCATCAACTG 
GAGAGGACAGGGTGGATGGA 
GTGGTAGTTGTGGTGTGACAGTTG 
GCTTGGAAAATAGTTCTGTTATGTTGA 
CGACTTGCCCAGCATCTTG 
TTGGCACTTGCATGGAGTTTT 
TGACCCCAACATGACCTCTG 
TGCGCCCATCTGTTGCT 
AACCAGAGGGAGTGAATCCAGAT 
TGCAGCAACAGTAAGGACAAACA 
GTCTCATCCAGTGGGAACCAGTA 
ACTCCTTTCGGTCACACATGCT 
CACATGGGCCGTGTAGAGTC 
GTGGTAGTTGTGGTGTGACAGTTG 
CTCCCCCGTGTGAGTTCTAATG 
TCATCGGAACCATGATCAACTG 
TCCAGTGCGTCGGCAAA 
AGTCCACTACAGCCTCTGTTAAGACA 
CAGAATTGTGGCCCCATCA 
GGACATGTCTCTCCATATGATGTGA 
 
 
cdc-42 
pmp-3  
cct-1 
cct-2 
 
CTGCTGGACAGGAAGATTACG 
GTTCCCGTGTTCATCACTCAT 
CCAGCCAAGCTTGAGGCTAT 
GGACTTGACTCGGCTGAACTTG 
 
CTCGGACATTCTCGAATGAAG 
ACACCGTCGAGAAGCTGTAGA 
TCAATGCGGCGTTTGGTA 
CGATGTCGATTCCCATATTGTG 
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Table 11 List of electrical devices  
cct-3 
cct-4 
cct-5 
cct-6 
cct-7 
cct-8 
enpl-1 
 
GCGTGAGAGTGGCCATCAG 
TGCACTTGAGCTCATTCCATACA 
TCTTGGAAGCAAAATCGTAAACC 
ACGAAATGGCGATTCAACATC 
TTGAGGGCAAGGATCAAGCT 
CGGCCGCTTTGTTGGA 
GAAACAAGAGAGGAAGATTCGATCA 
 
 
CGGCGATCGTCTTGCAA 
AACAGTGTGAATTGGTGACAATCC 
ACAGCATCGACAGCGATTTCT 
GTCGTCTTGTGCCGTCGAA 
CGTGGGATGATCTCGAAAGC 
TGTGGTGTCATTCCCATATGGA 
GCTTTTGAGCGGAGCTCCTT 
 
 
Instrument 
 
Manufacturer 
BINDER CB-150 
Mini Trans-Blot Cell 
Mini-Protean TGX, 10% ;10W; 10 
Mini-Sub Cell GT System W/ 7x7 
Mini-Trans-Blot Module 
C1000 Touch Thermal Cycler 
S1000 Thermal Cycler 
Mini-PROTEAN Tetra Cell 
PowerPac Basic HC 
Eppendorf 5430R, 5424, 5810R 
Thermomixer Comfort 
Hanna Instruments HI3220 
Heidolph unimax 1010 
ScanLaf Class 2 Mars 
VTX-3000L Mixer Uzusio 
Shaking platform RM S-30V 
INCUCELL MMM 
MIR-554-PE Cooled Incubator 
EnSpire Multimode Plate Reader 2300 
Precisa XB4200C 
Dri-Block DB-2D 
NanoDrop 8000 
Fusion Solo 
SteREO Discovery.V8 
ZEN imaging software 
Imager. Z1 
ZEISS Apotome .2 
Ec-Plan-Neofluar 20X-40X 
Achro-plan 10X 
Axiocam 506 mono 
Axio Zoom.V16 
 
BINDER GmbH  
Bio-Rad 
Bio-Rad 
Bio-Rad 
Bio-Rad 
Bio-Rad 
Bio-Rad 
Bio-Rad  
Bio-Rad  
Eppendorf  
Eppendorf  
HANNA Instruments  GmbH  
Heidolph Instruments GmbH  
Labogene  
LMS Co., Ltd  
M. Zipper GmbH  
MMM group  
Panasonic  
Perkin Elmer 
Precisa Gravimetrics AG  
Techne  
ThermoFisher Scientific  
Vilber Lourmat  
ZEISS  
ZEISS  
ZEISS  
ZEISS  
ZEISS  
ZEISS  
ZEISS  
ZEISS  
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2.2 Methods 
 
2.2.1 Tissue Culture 
 
2.2.1.1 Cell culture and differentiation 
 
hESCs and iPSCs were maintained on Geltrex (ThermoFisher Scientific) using 
mTeSR1 (Stem Cell Technologies). hESCs and iPSCs colonies were passaged using a 
solution of dispase (2 mg ml-1), and scraping the colonies with a glass pipette. All the cell 
lines used in this study were tested for mycoplasma contamination at least once every three 
weeks. 
Neural differentiation of H9 hESCs, H1 hESCs and iPSCs was performed following 
the monolayer culture method, following the STEMdiff Neural Induction protocol (Stem Cell 
Technologies) as described previously (Chambers, Fasano et al. 2009). Briefly, 
undifferentiated pluripotent stem cells were rinsed once with PBS and then added with 1 ml 
of Gentle Dissociation Reagent (Stem Cell Technologies) for 10 min. After the incubation 
period, cells were dislodged in 2ml DMEM F-12 supplemented with 10 mM ROCK inhibitor 
(Abcam). Then cells were centrifuged at 300g for 10 min, resuspended on STEMdiff Neural 
Induction Medium supplemented with 10 mM ROCK inhibitor and plated on polyornithine 
(15 mg ml-1)/laminin (10 mg ml-1)-coated plates (200,000 cells cm-2). For neuronal 
differentiation, NPCs were dissociated with Accutase (Stem Cell Technologies) and plated 
into neuronal differentiation medium (Dulbecco’s Modified Eagle Medium (DMEM)/F12, 
N2, B27 (ThermoFisher Scientific), 1 µg ml-1 laminin (ThermoFisher Scientific), 20 ng ml-1 
BDNF (Peprotech), 20 ng ml-1 GDNF (Peprotech), 1 mM dibutyryl-cyclic AMP (Sigma) and 
200 nM ascorbic acid (Sigma)) onto polyornithine/laminin-coated plates as described in 
(Vilchez, Boyer et al. 2012). Cells were differentiated for 1–2 months, with weekly feeding of 
neuronal differentiation medium. 
Endoderm differentiation of H9 hESCs was performed using STEMdiff Definitive 
Endoderm Kit (Stem Cell Technologies). Cardiomyocyte differentiation was performed as 
previously described (Rao, Pfeiffer et al. 2015). Briefly, confluent H1 hESCs were dissociated 
into single cells with Accutase at 37°C for 10 min followed by inactivation using two 
volumes of F12/DMEM. Cells were counted and 230000 cells/cm2 where plated in ITS 
medium (Corning), containing 1.25 µM CHIR 99021 (AxonMedchem) and 1,25 ng ml-1 
BMP4 (R&D), and seeded on Matrigel-coated 24-well plates. After 24 h, medium was 
changed to TS (transferrin/selenium) medium. After 48 h, medium was changed to TS 
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medium supplemented with 10 µM canonical Wnt-Inhibitor IWP-2 (Santa Cruz) for 48 h. 
Then, medium was changed to fresh TS until beating cells were observed at days 8 to 10. 
Finally, medium was changed to Knockout DMEM (ThermoFisher Scientific) supplemented 
with 2% FCS, L-Glutamine and Penicillin/Streptomycin until cells were used for downstream 
analysis.  
 
2.2.1.2 Transfection and lentiviral infection 
 
For transient lentiviral infections, hESC/iPSC colonies growing on Geltrex were 
incubated with mTesR1 medium containing 10 µM ROCK inhibitor (Abcam) for 2 h and 
individualized using Accutase. Hundred thousand cells were plated on Geltrex plates and 
incubated with mTesR1 medium containing 10 µM ROCK inhibitor for 1 day. Cells were 
infected with 5 µl of concentrated lentivirus. Plates were centrifuged at 800g for 1 h at 30°C. 
Cells were fed with fresh media the day after to remove virus. After 1 day, cells were selected 
for lentiviral integration using 1 µg ml-1 puromycin (ThermoFisher Scientific). Cells were 
collected for experimental assays after 4-6 days of infection. Alternatively, we generated 
stable transfected hESCs. In this case, hESC colonies growing on Geltrex were incubated 
with mTesR1 medium containing 10 µM ROCK inhibitor for 1 h and individualized using 
Accutase. Fifty thousand cells were infected with 20 µl of concentrated lentivirus in the 
presence of 10 µM ROCK inhibitor for 1 h. Cell suspension was centrifuged to remove virus, 
passed though a mesh of 40 µM to obtain individual cells, and plated back on a feeder layer of 
fresh mitotically inactive mouse embryonic fibroblasts (MEFs) in hESC media  (DMEM/F12, 
20% knockout serum replacement (ThermoFisher Scientific), 1 mM L-glutamine, 0.1 mM 
non-essential amino acids, β-mercaptoethanol and 10 ng ml-1 bFGF (Joint Protein Central)) 
supplemented with 10 µM ROCK inhibitor. After a few days in culture, small hESC colonies 
arose. Then, we performed 1 µg ml-1 puromycin selection during 2 days and colonies were 
manually passaged onto fresh MEFs to establish new hESC lines. 
HEK293T cells (ATCC) were plated on 0.1% gelatin-coated plates and grown in 
DMEM supplemented with 10% FCS and 1% non-essential amino acids (ThermoFisher 
Scientific) at 37°C, 5% CO2 conditions. Cells were transfected once they reached 80-90% 
confluency. 1 µg CCT8 overexpression plasmid (Sino Biological HG11492-UT) or 
pCDNA3.1 empty vector plasmid (Life Technologies V870–20) were used for transfection, 
using Fugene HD (Promega) following manufacturer’s instructions. 24 h after transfection, 
the cells were treated with 500 µg ml-1 Hygromycin B gold (Invivogen) during 16 h to select 
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for transfected cells. After 24 h incubation in normal medium, the cells were harvested for 
TRiC/CCT assembly experiments. 
 
 
2.2.1.3 Immunofluorescence 
 
Cells were ﬁxed with paraformaldehyde (4% in PBS) for 20 min, followed by 
permeabilization (0.2% Triton X-100 in PBS for 10 min) and blocking (3% BSA in 0.2% 
Triton X-100 in PBS for 10 min). Cells were incubated in primary antibody overnight at 4 °C. 
After washing with PBS, cells were incubated in secondary antibody and co-stained with 2 
mg ml-1 Hoechst 33342 (Life technologies) for 1h at RT. Finally, coverslips were fixed on 
glass slides with Mowiol (Sigma). 
 
 
2.2.1.4 Bacterial cultures 
 
Bacteria were cultured overnight either on LB plates or liquid LB culture 
supplemented with the desired antibiotics (100 mg/mL Carbenicillin and/or 10µg/mL 
Tetracyclin). LB medium was prepared according to the following recipe, using sterile 
technique: 
 
 
   Table 12 LB medium recipe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ingredient 
 
Amount 
Bacto-Tryptone 
Yeast extract 
NaCl 
H2O 
Bacto-Agar (for plates) 
10g 
5g 
10g 
up to 1L 
15g 
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2.2.2 C. elegans maintenance and assays 
 
 
2.2.2.1 C. elegans cultivation and lifespan 
 
Wild type and transgenic worms were cultured using standard methods (Brenner 1974) 
on NG plates seeded with OP50. Lifespan analyses were performed as described previously 
(Vilchez, Morantte et al. 2012). Animals were grown at 20ºC until day 1 of adulthood. 96 
animals were used per condition and scored every day or every other day (Amrit, Ratnappan 
et al. 2014). From the initial worm population, the worms that are lost or burrow into the 
medium as well as those that exhibit ‘protruding vulva' or undergo bagging were censored. 
Lifespans were conducted at either 20ºC or 25ºC as stated in the figure legends. For non-
integrated lines DVG9, DVG41, DVG44, DVG47-50 and DVG58, GFP positive worms were 
selected for lifespan studies. 
 
2.2.2.2 Heat stress assay 
 
For day 1 adulthood heat-shock assays, eggs were transferred to plates seeded with E. 
coli (OP50) bacteria and grown to day 1 of adulthood at 20ºC. Worms were then transferred 
to fresh plates with E. coli (HT115) containing L4440 and heat shocked at 34ºC. Worms were 
checked every hour for viability. For day 5 adulthood heat-shock assays, adult worms were 
transferred to fresh plates with E. coli (HT115) containing L4440 every day and then heat 
shocked at 34ºC at day 5. 
 
2.2.2.3 Oxidative stress assay 
 
Worms were synchronized by egg laying on OP50 (in case of OE lines) or EV RNAi 
on normal growth plates. For RNAi experiments, worms were transferred to the RNAi 
bacteria at L4 stage in order to prevent interference with the development. One day prior to 
the experiment, paraquat was diluted to 0.25M in ddH2O and added to the seeded plates to 
reach a final concentration of 7.5 mM. The plates were kept in dark. To prevent bagging, day 
5 adult worms were transferred to paraquat plates, scored daily and transferred every other 
day to a fresh plate. 
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2.2.2.4 Motility Assay 
 
Thrashing rates were determined as previously described (Brignull, Moore et al. 2006, 
Vilchez, Boyer et al. 2012). Animals were grown at 20ºC until L4 stage and then grown at 
20ºC or 25ºC for the rest of the experiment. Worms were fed with E. coli (OP50) bacteria. 
Worms were transferred at day 3 of adulthood to a drop of M9 buffer and after 30 seconds of 
adaptation the number of body bends was counted for 30 seconds. A body bend was defined 
as change in direction of the bend at the midbody (Chai, Shao et al. 2002). 
 
2.2.2.5 RNAi constructs 
 		 RNAi-treated strains were fed E. coli (HT115) containing an empty control vector 
(L4440) or expressing double-stranded RNAi. cct-2, cct-6, cct-7 and cct-8 RNAi constructs 
were obtained from the Vidal RNAi library. cct-5 and hsf-1 RNAi constructs were obtained 
from the Ahringer RNAi library. All constructs were sequence verified. 
 
2.2.2.6 C. elegans germline and gut immunostaining 
 
N2 and CB4037 strains were grown at 25ºC from hatching on OP50. Worms were 
dissected in dissection buffer (0.2% Tween 20, 1x Egg buffer, 20mM Sodium Azide) on a 
coverslip. Fixation was performed by adding formaldehyde buffer (1x Egg buffer, 0.2% 
Tween20 and 3.7% formaldehyde) and animals were frozen on dry ice between the coverslip 
and a poly-lysine coated slide (ThermoScientific). The coverslips were removed and the 
slides were placed for 1 min at -20oC in methanol, then washed twice with PBS 0.1% 
Tween20. After blocking for 30 min in PBST 10% donkey serum, anti-TCP1 alpha (Abcam, 
ab90357) antibody was added (1:1000) followed by overnight incubation in a humid chamber. 
Anti-Rat secondary antibody (Alexa Fluor 546) was added (1:400) for 2 h at room 
temperature. Finally, slides were mounted with Precision coverslip (Roth) using DAPI 
Fluoromount-G (Southern Biotech). Anti-TCP1 alpha is profiled for use in C. elegans by 
Abcam. We validated by western blot analysis that anti-TCP1 alpha recognizes this subunit in 
worms at the correct molecular weight. Native gel experiments confirmed that anti-TCP1 
alpha recognizes CCT1 in its monomeric form as well as part of the TRiC/CCT complex. 
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2.2.2.7 Nuclear staining in RNAi-treated C. elegans 
 
N2 wild-type worms were grown on E. coli (HT115) containing an empty control 
vector (L4440) from hatching until adulthood. The animals were then either kept on empty 
vector bacteria or fed with RNAi bacteria to cct-2 or cct-8 until day 4 of adulthood. Animals 
were then harvested and washed three times in M9 buffer. After 1 h incubation in methanol, 
worms were washed again three times with M9 buffer and mounted on a slide using DAPI 
Fluoromount-G (Southern Biotech). 
 
2.2.3 Molecular biology 
 
 
2.2.3.1 Plasmid DNA preparation 
 
2ml (mini) or 100ml (maxi) of bacterial overnight culture were pelleted at 8000g for 
10 min and DNA was isolated by Purelink Quick Plasmid Miniprep (Invitrogen) or Qiagen 
Maxi kits following manufacturer’s instructions.  
 
2.2.3.2 Construction of cct C. elegans expression plasmids. 
 
To construct the cct C. elegans expression plasmids, pPD95.77 from the Fire Lab kit 
was digested with SphI and XmaI to insert 3.6KB of the sur5 promoter. The resultant vector 
was then digested with KpnI and EcoRI to excise GFP and insert a multi-cloning site 
containing KpnI, NheI, NotI, XbaI, and EcoRI. T21B10.7.1 (cct-2), C07G2.3a.1 (cct-5), 
F01F1.8a.1 (cct-6) and T10B5.5a (cct-7) were PCR amplified from cDNA to include 5’ NheI 
and 3’ NotI restriction sites using NEB Q5 high fidelity polymerase and was then cloned into 
the aforementioned vector.  Y55F3AR.3a (cct-8) was amplified with 5’ NheI and 3’ EcoRI. 
All constructs were sequence verified. All the reagents were purchased from NEB and 
experiments were performed following the manufacturer’s instructions. 
 
2.2.3.3. Construction of cct-8 expression reporter construct 
 
To construct pDV077, pPD95.77 from the Fire Lab kit was digested with XbaI and 
XmaI. The promoter region and part of the first intron of Y55F3AR.3a (cct-8) was PCR 
amplified from N2 gDNA to include -600 to 100 and then cloned into the aforementioned 
vector using the same enzymes. 
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2.2.3.4 Transformation of E.coli 
 
Competent bacteria were either purchased from Thermofisher Scientific, or prepared 
as previously described (Inoue, Nojima et al. 1990). The bacteria were thawed on ice, 
incubated for 20 min with the plasmid DNA, and then heated at 42 ºC for 30-60s. After 5 min 
incubation on ice, the cells were grown in SOC medium for 1h while shaking at 800 rpm and 
cultured on a plate with the appropriate antibiotic for ON growth at 37 ºC. 
 
Table 13 Recipe for SOC medium 
 
 
 
 
 
 
 
 
 
 
 
2.2.3.5 Gene expression analysis 
 
For human cell samples, total RNA was extracted using RNAbee (Tel-Test Inc.). 
cDNA was generated using qScript Flex cDNA synthesis kit (Quantabio). SybrGreen real-
time qPCR experiments were performed with a 1:20 dilution of cDNA using a CFC384 Real-
Time System (Bio-Rad) following the manufacturer’s instructions. Data were analysed with 
the comparative 2ΔΔCt method using the geometric mean of ACTB and GAPDH as 
housekeeping genes. For C. elegans samples, total RNA was isolated from synchronized 
populations of approximately 2,000 adults using QIAzol lysis reagent (Qiagen). Data were 
analysed with the comparative 2ΔΔCt method using the geometric mean of cdc-42 and pmp-3 
as endogenous control (Hoogewijs, Houthoofd et al. 2008).  
 
2.2.3.6. Production of transgene worms by microinjection 
 
For generation of transgenic worm strains, a DNA plasmid mixture containing 
70 ng µl−1 of the corresponding plasmid and 20 ng µl−1 pPD93_97 (pmyo-3::GFP) was 
injected into the gonads of adult N2 hermaphrodite animals, using standard methods (Mello, 
 
Ingredient 
 
Amount 
Bacto-Tryptone 
Yeast extract 
NaCl 
KCl 
MgCl2 
MgSO4 
Glucose 
H2O 
20g 
5g 
2ml of 5M solution 
2.5ml of 1M solution 
10ml of 1M solution 
10ml of 1M solution 
20ml of 1M solution 
up to 1L 
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Kramer et al. 1991).  GFP-positive F1 progeny were selected. Individual F2 worms were 
isolated to establish independent lines. Control worms DVG9 (N2, ocbEx9[myo3p::GFP]) 
were generated by microinjecting N2 worms with 20 ng µl−1 pPD93_97. 
 
 
2.2.4 Biochemistry 
 
2.2.4.1 Protein biochemistry 
 
Cells were collected from tissue culture plates by cell scraping and lysed in protein 
cell lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM EDTA, 50 mM NaCl, 50 mM NaF, 1% 
Triton X-100, 0.1% SDS supplemented with 2 mM sodium orthovanadate, 1 mM 
phenylmethylsulphonyl fluoride and Complete mini protease) for 1h at 1,000 r.p.m. and 4°C 
in a Thermomixer. Samples were centrifuged at 10,000g for 15 min at 4°C and the 
supernatant was collected. Protein concentrations were determined with a standard BCA 
protein assay (Thermoscientific). Approximately 20–30 µg of total protein was separated by 
SDS–PAGE, transferred to nitrocellulose membranes (Whatman) and subjected to 
immunoblotting.  
 
 
2.2.4.2 Blue native gel immunoblotting of TRiC/CCT complex. 
 
For experiments with hESCs (H9 and H1) and their NPC counterparts, cells were 
collected in lysis buffer (50 mM Tris-HCl (pH 7.5), 1 mM dithiothreitol and 10% glycerol 
supplemented with protease inhibitor cocktail (Roche)) and lysed by passing 10 times through 
a 27-gauge needle attached to a 1 ml syringe. Lysate was centrifuged at 16,000g for 10 min at 
4°C. 50 µg of total protein was run on a 3-13% gel in deep blue cathode buffer (50 mM 
Tricine, 7.5 mM Imidazole, and 0.02 % Coomassie G250) at 4°C for 3 hour at 100V and then 
exchange deep blue cathode buffer to slightly blue cathode buffer (50 mM Tricine, 7.5 mM 
Imidazole, and 0.002 % Coomassie G250) and run at 100V overnight. Proteins were then 
transferred to a PVDF membrane at 400 mV for 3 hours by semi-dry blotting. Extracts were 
also analyzed by SDS-PAGE to determine CCT subunit expression levels and loading control. 
 
2.2.4.3 Filter trap assay  
 
 Worms were grown at 20ºC until L4 stage and then grown at 25ºC for the rest of the 
experiment. Day 3 adult worms were collected with M9 buffer and worm pellets were frozen 
with liquid N2. Frozen worm pellets were thawed on ice and worm extracts were generated by 
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glass bead disruption on ice in non-denaturing lysis buffer (50mM Hepes pH 7.4, 150 mM 
NaCl, 1mM EDTA, 1% Triton X100) supplemented with EDTA-free protease inhibitor 
cocktail (Roche). Worm and cellular debris was removed with 8000g spin for 5 min. 
Approximately 100 µg of protein extract was supplemented with SDS at a final concentration 
of 0.5% and loaded onto a cellulose acetate membrane assembled in a slot blot apparatus 
(BioRad). The membrane was washed with 0.1% SDS and retained Q67-GFP was assessed by 
immunoblotting for GFP (ImmunoKontakt, 210-PS-1GFP). Extracts were also analyzed by 
SDS-PAGE to determine protein expression levels. 
 iPSCs were collected in non-denaturing lysis buffer supplemented with EDTA-free 
protease inhibitor cocktail and lysed by passing 10 times through a 27-gauge needle attached 
to a 1 ml syringe. Then, we followed the filter trap protocol described above. The membrane 
was washed with 0.1% SDS and retained polyQ proteins were assessed by immunoblotting 
for anti-polyQ-expansion diseases marker antibody (Millipore, MAB1574). Extracts were 
also analyzed by SDS-PAGE to determine HTT protein expression levels. 
 
 
2.2.5 Statistics  
 
PRISM 6 software was used for statistical analysis to determine median and 
percentiles. For Lifespan and heat stress assays, P-values were calculated using the log-rank 
(Mantel–Cox) method. The P-values refer to experimental and control animals in a single 
experiment. For the rest of experiments, unless stated otherwise, two-tailed unpaired students’ 
t-test was used to check for statistical significance. Error bars represent standard error of the 
mean (S.E.M.). (*p<0.05   **p<0.01  ***p<0.001) 
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3 Results  
 
 
3.1 Investigating the impact of PSME4 on stem cell biology  
 
3.1.1 PSME4 is not essential for stemness 
 
In  order  to  validate  the  results  we  obtained  from  our  quantitative  proteomics 
screen which demonstrated elevated expression of the proteasome activator PSME4, we 
compared the expression of PSME4 in H9 hESC line with H9 cells differentiated into 
neural  progenitor  cells  (NPCs)  and  neurons.  We observed that the levels of PSME4 
decreases remarkably upon differentiation to NPCs and neurons (Figure 1a-b), but 
surprisingly increases remarkably upon differentiation towards endoderm lineage (Figure 
1c). To check whether PSME4 expression is reprogrammable, we compared the levels of 
PSME4 in fibroblasts and induced pluripotent stem cells (iPSCs) and observed an increase in 
expression (Figure 4d). As PSME4 is highly increased in hESCs, we reasoned that it might 
play an essential role in regulating the stem cell function. In order to investigate the role of 
PSME4 in stemness, we established knockdown (KD) H9 cell lines, by using two distinct 
short hairpin RNAs (shRNA) designed to target PSME4, and a non-targeting shRNA as 
control. These stable cell lines demonstrated a significant decrease in PSME4 expression, 
both at protein and mRNA level (Figure 1e-f). 
To elucidate whether and how the hESCs downregulated for PSME4 are affected, we 
checked for pluripotency markers such as OCT4, NANOG and SOX2 as well as markers of 
the distinct germlayers such as GATA4, AFP or NESTIN to find out whether these cells show 
a predisposition towards any cellular lineage.  As  demonstrated  in Figure 2, no  remarkable  
difference  was  observed among PSME4 KD and control cells in expression of these 
markers. Although PSME4 KD cells did not exhibit any difference in expression of 
pluripotency markers compared to control cells, it could be hypothesized that these cells 
might be limited in their differentiation capabilities. In particular, the observation that 
PSME4 increases in endoderm progenitor cells compared to hESCs,  hints towards the 
possibility that PSME4 might be essential for endodermal function and thus for 
differentiation into this lineage. In addition, we also examined  PSME4 KD hESCs capability 
to differentiate towards ectodermal lineage.  
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Figure 1. PSME4 is highly expressed in most of pluripotent stem cells and its expression is 
reprogrammable. (a-d) hESCs or iPSCs demonstrate higher PSME4 expression compared more 
differentiated cells of ectoderm and mesoderm lineages. Endoderm progenitor cells have increased 
PSME4 expression compared to hESCs. (e-f). Downregulation of PSME4 in hESCs by shRNA leads 
to efficient knockdown. All the statistical comparisons were made by Student’s t-test for unpaired 
samples. P-value: *(P<0.05), **(P<0.01), *** (P<0.001), **** (P<0.0001) (n= 3 independent 
experiments). 
 
However, PSME4 KD hESCs could differentiate into either endoderm or ectoderm 
progenitors, without any major difference in expression of lineage specific markers. No 
difference was observed in the expression of endoderm markers (GATA4, SOX17, CXCR4, 
CD117) between PSME4KD and control cells . Although some NPC or neural markers such 
as AADC, PAX6 or TH showed higher expression levels when PSME4 is downregulated, this 
was observed only in one of the KD lines. In addition, no significant difference could be 
detected in the cellular morphology after neural differentiation of PSME4 KD cells compared 
to the control cell line (Figure 2 c). Thus, PSME4 appears to be dispensable for maintaining 
the pluripotency and differentiation into endoderm and ectoderm lineages. 
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Figure 2. Lack of PSME4 does not affect the pluripotency of hESCs. (a) Downregulation of 
PSME4 does not lead to loss of pluripotency, as evidenced by the unaffected expression of 
pluripotency and lineage specific markers. (b-c) PSME4 KD hESCs does not exhibit any significant 
difference in expression of endoderm or neural differentiation markers when differentiated into these 
lineages (d) PSME4 KD cells do not exhibit any abnormalities upon differentiation into NPCs, neither 
morphologically, nor in expression of NPC marker PAX6 (After 6 days of neural induction, scale bar 
represents 50 µm). All the statistical comparisons were made by Student’s t-test for unpaired samples. 
P-value: *(P<0.05), **(P<0.01), *** (P<0.001), **** (P<0.0001) (n= 3 independent experiments). 
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3.2 Impact of PSME4 on longevity and stress resistance 
 
 
3.2.1 psme4 does not affect longevity in C. elegans 
 
 
As impaired proteostasis is related with a myriad of age-associated diseases and 
aging, and taken the relevance of stem cell proteostasis in organismal aging (Vilchez, Boyer 
et al. 2012, Vilchez, Morantte et al. 2012), we asked whether downregulation or 
overexpression of PSME4 orthologues could affect longevity in worms. C. elegans has two 
orthologues for PSME4: C14C10.5 and T28B8.3. As C14C10.5 (from now referred to as 
psme4) exhibits more similarity in the protein sequence to the mammalian gene (Figure 3a) 
(Goujon, McWilliam et al. 2010, Sievers, Wilm et al. 2011), we mainly concentrated on this 
orthologue. Worms fed with siRNA against the worm PSME4 orthologue at 20°C (normal 
condition) and 25°C (mild proteotoxic stress) did not show any difference in their lifespan 
compared to the control worms (Figure 3b-c). We reasoned that this result might be due to 
inefficient RNAi, and therefore we repeated the lifespan experiment with rrf-3 strain. This 
strain is known to be more sensitive to RNAi due to lack of the RNA polymerase RRF-3 
(Simmer, Tijsterman et al. 2002). Once again, no significant difference was observed in the 
longevity of control and downregulated worms (Figure 3d). In order to investigate the impact 
of psme4 overexpression on longevity, we created lines that overexpress psme4 in the soma 
of the worms (Figure 3e). This overexpression by extrachromosomal array did not have a 
significant impact on the longevity of the worms under normal conditions when compared to 
the control line (Figure 3f). This data indicates that psme4 does not affect the longevity of C. 
elegans under normal growth conditions. 
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Figure 3. Misregulation of psme4 does not affect C. elegans longevity.  (a) Protein alignment 
reveals the higher similariy of C14C10.5 to the human PSME4. Multisequence alignement was 
performed using Clustal Omega (EMBL-EBI). (b-d) Downregulation of psme4 by RNAi does not 
affect  wildtype C. elegans lifespan at 20 or 25 °C, or the lifespan of RNAi sensitive rrf-3 strain. (e). 
Somatic overexpression of psme4 by extrachromosomal array leads to significant increase of psme4 
expression as demonstrated by qPCR analysis. (f). Somatic overexpression of psme4 is not sufficient 
to extend C. elegans lifespan. All the statistical comparisons were made by Student’s t-test for 
unpaired samples. P-value: *(P<0.05), **(P<0.01), *** (P<0.001), **** (P<0.0001) (n= 3 
independent experiments). 
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3.2.2 psme4 mildly affects C. elegans stress resistance  
 
 
As we could not observe any phenotypes in psme4 KD hESCs or C. elegans, we 
hypothesized that it might be dispensable for maintaining the proteostasis under normal 
conditions, but might be important for helping cells cope with proteotoxic stress. In order to 
investigate this hypothesis, we exposed the worms to two major causes of proteotoxicity, heat 
and oxidation, and evaluated their survival under stress conditions. Surprisingly, when the 
worms were exposed to heat, we observed a moderate but significant increase in the survival 
of worms upon downregulation, and a mild decrease in survival upon overexpression of 
psme4 (Figure 4a-b). In case of oxidative stress, we observed a minor, but statistically 
significant increase in the survival in psme4 OE worms in one of the overexpression lines 
(Figure 4d), whereas there were no significant differences in stress resistance of psme4 KD 
worms (Figure 4c-d).  
 
 Based on the mild increase in stress resistance of psme4 OE worms, we speculated 
that PSME4 might be also indispensable for maintenance of mammalian cells under normal 
conditions, but might be crucial for the capability of these cells to cope with proteotoxic 
stress under specific conditions or developmental stage. Intrigued by the remarkable increase 
in the expression of PSME4 upon differentiation towards endoderm lineage, which is in stark 
contrast with the expression pattern in other lineages, and drastic fluctuations in protein 
oxidation states during differentiation process (Hernebring, Brolén et al. 2006), we asked 
whether PSME4 could be essential for clearance of oxidized proteins in endoderm cells. To 
test this hypothesis, we checked the levels of protein carbonylation both in hESCs or their 
endoderm counterparts. Again, we were unable to discover any differences in the levels of 
protein carbonylation when PSME4 was downregulated either in hESCs or in endoderm cells 
(Figure 4e). 
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Figure 4.  Misregulation of psme4 leads to minor changes in proteotoxic stress resistance of C. 
elegans. (a) Downregulation of psme4 increases the stress resistance of worms (b) psme4 OE 
increases the heat sensitivity of C. elegans (c). Downregulation of psme4 does not affect resistance 
against oxidative stress, whereas one of the two psme4 OE lines demonstrates a very mild increase 
in oxidative stress resistance (d). Neither hECSs nor their endoderm counterparts accumulate more 
oxidized proteins upon downregulation of PSME4 (e). All the statistical comparisons were made by 
Student’s t-test for unpaired samples. P-value: *(P<0.05), **(P<0.01), *** (P<0.001), **** 
(P<0.0001) (n= 3 independent experiments). 
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3.3 Investigating the impact of chaperome network on 
stem cell biology 
 
3.3.1 CCT complex is indispensable for stem cell survival and 
pluripotency 
 
  3.3.1.1 CCT subunits decrease during hESC differentiation 
 
Taken the important role of the UPS in stem cell identity, we asked whether other 
components of the PN could be of similar importance. To answer this, we compared these 
cells to their NPC and neural counterparts by quantitative mass spectrometry and RNA 
sequencing (Noormohammadi, Khodakarami et al. 2016).  Among the major proteostasis 
components, we discovered the chaperome network to exhibit dramatic differences in 
expression in hESCs and their NPC and neural counterparts. At the protein level, we found 
that 36 out of 122 identified chaperome components decrease during differentiation into 
NPCs. In contrast, 27 chaperome components were increased during neural differentiation. 
Among the 44 chaperome components decreased in terminally differentiated neurons 
compared with hESCs, 28 proteins were already down-regulated during differentiation into 
NPCs. 
 Notably, several subunits of the chaperonin TRiC/CCT complex decreased at both 
transcript and protein levels during neural differentiation of hESCs. TRiC/CCT is required 
for cell viability as a key component of the proteostasis network that facilitates the folding of 
approximately 10% of the eukaryotic proteome (Yam, Xia et al. 2008, Lopez, Dalton et al. 
2015). TRiC/CCT not only assists the folding of newly synthesized proteins (Etchells, Meyer 
et al. 2005) but also binds to misfolded proteins regulating their aggregation (Priya, Sharma 
et al. 2013). Given the crucial role of this molecular chaperonin in proteostasis, we further 
assessed its regulation on pluripotent stem cells. In eukaryotes, the hetero-oligomeric 
TRiC/CCT complex consists of two stacked rings of eight paralogous subunits each (Leitner, 
Joachimiak et al. 2012). In our quantitative proteomics assay, we found that CCT3, CCT4 
and CCT8 subunits are significantly increased in hESC compared with NPCs. We confirmed 
these results by western blot analysis and found that other subunits also decrease during 
neural and neuronal differentiation (i.e., CCT2, CCT6A and CCT7) (Figure 5a). The decrease 
in the protein amount of CCT subunits correlated with a reduction of the mRNA levels 
during differentiation (Figure 5b). Differentiation into either endoderm or mesoderm induced 
a similar decrease (Figure 5c-f). 
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Figure 5. Expression of CCT subunits decreases during differentiation. (a), (c) and (e) Western 
blot analysis with antibodies to CCT8, CCT7, CCT6A, CCT2 and CCT1. β-actin is the loading 
control. In (a) and (c) the differentiation was performed with the H9 hESC line whereas in (e) H1 
hESCs were used. (b) CCT subunits relative expression to H9 hESCs represents the mean ± s.e.m. of 
three independent experiments. (d) CCT subunits relative expression to H9 hESCs represents the 
mean ± s.e.m. (n= 7 independent experiments). (f) CCT subunits relative expression to H1 hESCs 
represents the mean ± s.e.m. of three independent experiments. All the statistical comparisons were 
made by Student’s t-test for unpaired samples. P-value: *(P<0.05), **(P<0.01), *** (P<0.001), **** 
(P<0.0001).  
a. 
 
c. 
 
e. 
 
b. 
 
d. 
 
f. 
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Consistent with the ability of hESCs to self-renew indefinitely while maintaining their 
undifferentiated state (Thomson, Itskovitz-Eldor et al. 1998, Miura, Mattson et al. 2004), the 
expression of CCT subunits and pluripotency markers did not differ depending on the passage 
number (Figure 6a-b). Taken together, our results indicate that hESCs are able to maintain 
enhanced expression of CCT subunits under unlimited proliferation in their undifferentiated 
state. However, the levels of subunits such as CCT8 or CCT2 decrease when hESCs 
differentiate into distinct cell lineages. Thus, increased levels of CCT subunits could be an 
intrinsic characteristic of hESCs linked to their immortality and identity. 
 
Figure 6. H1 hESCs and iPSCs exhibit increased expression of CCT subunits. (a) Protein levels of 
CCT subunits do not differ with passage in H9 hESCs. (b) Data represent the mean ± s.e.m. of the 
relative expression levels to H9 hESCs passage 31-33 (n= 3 independent experiments). All the 
statistical comparisons were made by Student’s t-test for unpaired samples. P-value: *(P<0.05), 
**(P<0.01), *** (P<0.001), **** (P<0.0001). 
 
3.3.1.2 Increased expression of CCT8 induces TRiC/CCT assembly 
 
Prompted by these findings, we asked whether increased levels of CCT subunits 
resulted into more assembled TRiC/CCT complexes in hESCs. Although both hESCs and 
NPCs have similar levels of total CCT1 subunits (Figure 6a, Figure 7a-b) hESCs lines 
exhibited a dramatic increase in the assembly of TRiC/CCT in the form of two stacked rings 
(Figure 7a-b). Similarly, iPSCs also had increased TRiC/CCT assembly compared with 
differentiated cells (Figure 7c). Since all the subunits are required for TRiC/CCT function 
(Spiess, Meyer et al. 2004), downregulated CCT subunits could become structural limiting 
factors during differentiation and modulate the decrease of TRiC/CCT assembly. An 
intriguing possibility is that specific subunits can also function as assembly activators. A 
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comparison between the levels (relative to CCT1) of the different subunits in hESCs and 
NPCs showed that CCT8 is the most abundant subunit in both cell types despite decreasing 
during differentiation (Figure 7d).   
Figure 7. Ectopic expression of CCT8 is sufficient to increase TRiC/CCT assembly. (a-c) Native 
gel electrophoresis of H9, H1, iPSC and NPCs extracts. Extracts were resolved by SDS-PAGE and 
immunoblotting for analysis of total CCT subunit levels and β-actin loading control. (d). Label-free 
quantification (LFQ) of CCT protein levels relative to CCT1. All detected CCT subunits were 
quantified by their log2 fold change in LFQ intensities relative to CCT1. Graphs represent the mean ± 
s.e.m. (hESCs (n= 9), NPCs (n= 6)). (e). Native gel electrophoresis of HEK293T cell extracts 
followed by immunoblotting with CCT1 antibody (two different exposure times of the same 
membrane are shown). Extracts were resolved by SDS-PAGE and immunoblotting for analysis of 
total CCT8 and CCT1 subunit levels and β-actin loading control. 
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These findings indicate that CCT8 is not stoichiometric limiting for TRiC/CCT assembly. 
Thus, we asked whether an increase in the total protein levels of CCT8 could trigger 
TRiC/CCT assembly. Strikingly, ectopic expression of CCT8 induced an increase in 
TRiC/CCT assembly whereas the total protein levels of CCT1 remained similar (Figure 7e). 
In contrast, we found a decrease in the levels of CCT1 in its monomeric form upon CCT8 
overexpression (Figure 7e). Collectively, our results suggest that hESCs have an intrinsic 
proteostasis network characterized by high levels of TRiC/CCT complex. During 
differentiation, the levels of distinct CCT subunits decrease and diminish the assembly of 
TRiC/CCT chaperonin. In addition, we identified CCT8 as a potential activator of TRiC/CCT 
assembly by using hESCs as a model to study proteostasis. 
 
3.3.1.3 Loss of CCT subunits affects hESC identity 
 
With the strong connection between hESC identity, CCT8 expression and enhanced 
assembly of TRiC/CCT complex, we asked whether increased levels of CCT8 contribute to 
maintain hESC function. Given that TRiC/CCT is essential for cell viability (Lopez, Dalton et 
al. 2015), loss of CCT subunits induces cell death and detachment (Figure 8a). To avoid these 
effects, we induced a mild knockdown of approximately 30-50% by transient lentiviral 
transduction. Notably, downregulation of CCT8 resulted in decreased levels of pluripotency 
markers (Figure 8b). We hypothesized that high CCT8 expression impinges upon hESC 
function via enhanced assembly of TRiC/CCT complex. Since mutation or loss of a single 
subunit is sufficient to impair the activity of the complex (Spiess, Meyer et al. 2004), we 
knocked down other subunits (i.e., CCT2, CCT6A and CCT7) to determine whether increased 
TRiC/CCT is required for hESC function. As with CCT8 knockdown, decreased levels of 
these subunits affected the expression of pluripotency markers (Figure 8b). We performed 
these experiments in an independent hESC line as well as iPSC lines and obtained similar 
results (Figure 8c-d). 
In addition, loss of CCT levels induced the expression of markers of the distinct germ 
layers (Figure 9b). Since we observed an up-regulation in specific markers of the three germ 
layers, our data suggest that hESCs undergo a decline of pluripotency upon knockdown of 
CCT subunits but they do not differentiate into a particular cell lineage. Although we cannot 
discard a role of free monomeric CCT subunits, our results indicate that increased levels of 
the TRiC/CCT complex are required for hESC identity. 
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Figure 8. Knockdown of CCT subunits affects pluripotency of PSCs. (a) Acute knockdown of 
CCT subunits induces cell death and detachment of H9 hESCs. Representative images of two 
independent experiments. (b-d) Real Time PCR analysis of pluripotency markers in H9, H1 and 
iPSCs. Knockdown of CCT8, CCT2, CCT6A or CCT7 decrease the expression of pluripotency 
markers. Graphs (relative expression to NT shRNA) represent the mean ± s.e.m. of at least three 
independent replicates. All the statistical comparisons were made by Student’s t-test for unpaired 
samples. P-value: *(P<0.05), **(P<0.01), *** (P<0.001), **** (P<0.0001). 
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Figure 9. Knockdown of CCT subunits affects the expression of germ layer markers in different 
cell lines. (a) Knockdown of CCT7 induces a decrease in OCT4 protein levels. β-actin is the loading 
control.  (b) Real Time PCR analysis of germ layer markers in H9 , H1 and iPSCs  (relative 
expression to NT shRNA). Data represent Graph represents the mean ± s.e.m. of four independent 
experiments. All the statistical comparisons were made by Student’s t-test for unpaired samples. P-
value: *(P<0.05), **(P<0.01), *** (P<0.001). 
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3.3.1.4 TRiC/CCT complex determines proteostasis of pluripotent stem cells 
 
Because the TRiC/CCT complex modulates aggregation of damaged and misfolded 
proteins (Priya, Sharma et al. 2013), we asked whether this chaperonin is required for 
increased proteostasis of pluripotent stem cells. To tackle this question, we used iPSCs 
derived from Huntington’s disease patients (HD-iPSCs). HD is an autosomal dominant 
neurodegenerative disorder caused by the expansion of a CAG triplet repeat region in the 
huntingtin gene (HTT), which translates into a polyglutamine stretch (polyQ) in the protein 
and results in proteotoxicity and aggregation (Finkbeiner 2011). In its wild-type form, HTT 
contains 6-35 glutamine residues. However, in individuals affected by HD, it contains greater 
than 35 glutamine residues and longer repeats predict younger disease onset (Langbehn, 
Hayden et al. 2010, Finkbeiner 2011). Here we used three different control iPSC lines and 
HD-iPSCs from four donors with different allelic series (i.e., polyQ57, polyQ60, polyQ71 and 
polyQ180). These HD-iPSC lines possess one mutant copy of huntingtin gene but also one 
normal allele (Figure 10a-b). Although the levels of mutant HTT were lower compared to the 
normal protein, HD-iPSCs exhibited significant amounts of mutant polyQ-expanded HTT 
protein (Figure 10a-b). In iPSCs that express longer CAG repeat expansions (polyQ180), the 
differences between the levels of mutant and normal HTT were more dramatic (Figure 10b). 
Nevertheless, we confirmed the expression of mutant HTT in these iPSCs by using an 
antibody that detects remarkably better polyQ-expanded HTT than wild type HTT (Trottier, 
Lutz et al. 1995, Consortium 2012) (Figure 10b-e). To examine the aggregation of mutant 
HTT in HD-iPSCs, we performed filter trap analysis that allows for quantification of polyQ 
aggregates (Vilchez, Morantte et al. 2012). Although HD-iPSCs expressed significant levels 
of polyQ-expanded HTT, these cells did not exhibit accumulation of detectable polyQ 
aggregates compared with control iPSCs as assessed by both filter trap and 
immunohistochemistry analyses (Figure c, e, f and g). However, a collapse in proteostasis 
induced by proteasome inhibition triggered the accumulation of polyQ aggregates in HD-
iPSCs (Jeon, Lee et al. 2012) (Figure 10f). Loss of CCT subunits enhances aggregation of 
mutant HTT and wor6sens HD-related changes in yeast, C. elegans and mammalian neuronal 
models (Nollen, Garcia et al. 2004, Kitamura, Kubota et al. 2006, Tam, Geller et al. 2006). 
Thus, increased TRiC/CCT assembly induced by high levels of CCT subunits could 
contribute to maintain the proteostasis of mutant HTT in iPSCs. We found that knockdown of 
CCT8 and other CCT subunits trigger the accumulation of polyQ aggregates without affecting 
the mutant HTT total protein levels in HD-iPSCs (Figure 10d-e). 
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Figure 10. Knockdown of CCT subunits impairs proteostasis of pluripotent stem cells. (a) 
Western blot analysis of control and HD-iPSC lysates with antibodies to HTT and β-actin. Arrow 
indicates mutant polyQ-expanded HTT. (b) In HD polyQ180-expressing iPSCs, the levels of mutant 
HTT are dramatically decreased compared with normal HTT copy. The expression of polyQ180 HTT 
was confirmed by using an antibody that detects polyQ-expanded mutant HTT. (c) Filter trap analysis 
shows that HD-iPSCs does not have increased levels of polyQ aggregates compared to control iPSCs 
(detected by anti-polyQ-expansion diseases marker antibody). However, knockdown of a single CCT 
subunit triggers the accumulation of polyQ aggregates. (d) Knockdown of different CCT subunits in 
HD polyQ71 iPSC line #1 results in a similar increase of polyQ aggregates. Right panel: SDS-PAGE 
analysis with antibodies to HTT and β-actin loading control. (e) Knockdown of a single CCT subunit 
triggers the accumulation of polyQ aggregates in both polyQ71 iPSC line #2 and polyQ180 iPSCs. 
Right panel: PolyQ-expanded mutant HTT antibody was used to confirm that the total protein levels 
of mutant HTT do not change upon knockdown of CCT subunits. (f) Filter trap analysis shows that 
proteasome inhibition with MG-132 for 12 h results in increased levels of polyQ aggregates in the 
pellet of HD Q71-iPSCs (line #1). However, proteasome inhibition does not induce accumulation of 
polyQ aggregates in control iPSC line #2 (polyQ21). (g) Immunocytochemistry of control iPSC line 
#2 (Q21) and HD Q71-iPSC line #1 treated with 5 µM MG-132 (proteasome inhibitor) for 12 h. 
Expanded polyQ antibody was used to detect polyQ aggregates. Cell nuclei were stained with 
Hoechst 33342.  Scale bar represents 20 µm. 
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These results were observed in all the HD-iPSC lines tested whereas knockdown of CCT 
subunits did not induce accumulation of polyQ aggregates in control iPSCs (Figure 10c-e). 
Remarkably, loss of different CCT subunits (i.e., CCT2, CCT6A, CCT7 and CCT8) had 
similar effects (Figure 10d), indicating that the TRiC/CCT complex modulates polyQ 
aggregation in HD-iPSCs. HD-iPSCs represent a valuable resource to gain mechanistic 
insights into HD (Consortium 2012). Neuronal dysfunction and death occurs in many brain 
regions in HD, but striatal neurons expressing cAMP-regulated phosphoprotein (DARPP32) 
undergo the greatest neurodegeneration (Vonsattel, Keller et al. 2008). HD-iPSCs can be 
terminally differentiated into neurons (including DARPP32-positive cells) that exhibit HD-
associated phenotypes such as cumulative risk of death over time and increased vulnerability 
to excitotoxic stressors (Consortium 2012). Furthermore, proteotoxic stress via autophagy 
inhibition or oxidative stress results in higher neurodegeneration of HD cells compared with 
controls (Consortium 2012). Despite these phenotypes, mutant HTT-expressing neurons 
present important limitations for disease modeling such as lack of robust neurodegeneration, 
polyQ aggregates and gene expression changes resembling HD (Consortium 2012, Jeon, Lee 
et al. 2012). Despite the efforts to detect polyQ aggregates under different conditions (for 
instance adding cellular stressors), the presence of inclusions has not been observed in 
neurons derived from HD-iPSCs (Consortium 2012, Jeon, Lee et al. 2012). The lack of 
inclusions in these cells could reflect the long period of time before aggregates accumulate in 
HD (Consortium 2012). Consistently, HD human neurons do not accumulate detectable 
polyQ aggregates at 12 weeks after transplantation into HD rat models whereas these 
inclusions are observed after 33 weeks of transplantation (Jeon, Lee et al. 2012). The lack of 
inclusions in HD neurons could reflect the long period of time before aggregates accumulate 
in HD (Consortium 2012). To assess whether loss of CCT subunits triggers 
neurodegeneration and polyQ aggregation in these cells, we differentiated three HD-iPSC 
lines (Q57, Q71 and Q180) into striatal neurons (Aubry, Bugi et al. 2008). Among those cells 
expressing the neuronal marker MAP2, approximately 50% also expressed DARPP32 as 
previously described (Aubry, Bugi et al. 2008, Consortium 2012) (Figure 11a). As with 
proteasome inhibitor treatment, we could not detect polyQ aggregates in mutant HTT-
expressing neurons upon knockdown of CCT subunits by either immunofluorescence or filter 
trap (Figure 11b, c). However, knockdown of CCTs resulted in increased cell death of HD 
neuronal cultures assessed by cleaved caspase-3 quantification whereas it did not induce cell 
death in control neurons (Figure 11d). In contrast, proteasome inhibition triggered cell death 
at the same extent in both control and HD neurons (Consortium 2012) (Figure 11d).  
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Figure 11. Dysfunction  of TRiC/CCT  induces activation of caspase-3 in neurons derived from 
HD-iPSCs. (a) 
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 (b) Immunofluorescence of neurons derived from iPSCs with expanded polyQ antibody and 
Hoechst 33342. Scale bar represents 20 µm. The images are representative of three independent 
experiments. (c) Filter trap analysis of neurons derived from iPSCs. Expanded polyQ antibody 
was used to detect polyQ aggregates. MG-132: 5µM MG-132 for 24 h. The images are 
representative of two biological replicates. (d) Percentage of activated caspase-3- positive nuclei. 
Graph represents the mean ± s.e.m. of the percentage observed in 4 independent neuronal 
differentiation experiments (we assessed approximately 150 total nuclei in each independent 
experiment). MG-132: 5 µM MG-132 for 24 h. Activated caspase-3-positive   nuclei were stained 
with antibody to cleaved caspase-3.  Total number of cells was evidenced after staining of nuclei 
with Hoechst 33342. All the statistical comparisons were made by Student’s t-test for unpaired 
samples. P-value: *(P<0.05), **(P<0.01), *** (P<0.001). 
 
 
 
 
These results indicate that mutant HTT-expressing neurons are more susceptible to 
TRiC/CCT dysfunction and provide a link between downregulation of CCTs with onset of 
neurodegeneration during aging in HD. 
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3.3.1.5 Somatic overexpression of CCT8 extends organismal lifespan 
 
 
Our results indicate that increased TRiC/CCT complex is a key determinant of 
proteostasis of immortal hESCs/iPSCs. However, the levels of CCT subunits decreased upon 
differentiation. During human brain aging, the expression of CCTs is further repressed 
(Brehme, Voisine et al. 2014). With the strong correlation between cct levels, differentiation 
and aging, we asked whether inducing TRiC/CCT assembly in somatic post-mitotic cells 
could have a positive role in longevity. To examine the impact of TRiC/CCT on organismal 
aging and proteotoxic resistance, we used the nematode C. elegans. In this organism, CCT 
transcripts are detected in most tissues and developmental stages (Hill, Hunter et al. 2000). 
The role of TRiC/CCT complex in proliferating cells during C. elegans development has been 
extensively studied (Lundin, Srayko et al. 2008). Disruption of TRiC/CCT assembly by 
knockdown of different CCT subunits causes a variety of defects in cell division and results in 
embryonic lethality (Gonczy, Echeverri et al. 2000, Simmer, Moorman et al. 2003, Lundin, 
Srayko et al. 2008, Green, Kao et al. 2011). These effects are partially mediated by a collapse 
in microtubule function as a consequence of diminished folding of tubulin by TRiC/CCT 
(Lundin, Srayko et al. 2008). In addition, loss of different cct subunits during post-embryonic 
developmental stages results in larval arrest, body morphology alterations as well as defects in 
developing gonads and sterility, indicating a key role of the TRiC/CCT complex in C. elegans 
development (Lundin, Srayko et al. 2008). In adult worms, the only proliferating cells are 
found in the germline whereas somatic tissues are formed exclusively by post-mitotic cells 
(Hubbard 2007). To examine the expression of CCTs in germ cells, we dissected the germline 
and intestine from adult C. elegans and compared the levels of CCT subunits by 
immunohistochemistry. We found that CCT-1 subunit is enhanced in germ cells compared 
with the intestine (Figure 12a), suggesting that CCTs are highly expressed in the germline. 
Notably, knockdown of cct subunits during adulthood dramatically decreased the number of 
germ cells destabilizing the germline (Figure 12b). Accordingly, we observed a dramatic 
decrease in the number of laid eggs after 2 days of cct RNAi treatment during adulthood 
(Figure 12c). Overall, these data suggest that high levels of TRiC/CCT complex are essential 
for proliferating cells and germline stability. However, knockdown of cct subunits during 
adulthood did not decrease lifespan in wild-type worms (Figure 12d). 
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Figure 12 Knockdown of CCT subunits destabilizes C. elegans germline. (a) Gonad and intestine 
immunostaining with CCT-1 antibody from day 1-adult wild-type worms.  Cell nuclei were stained 
with DAPI.  White arrow indicates gonad and red arrow indicates intestine. Scale bar represents 
20 µm. DIC= differential interference contrast. The images are representative of two independent 
experiments. (b) Nuclei staining with DAPI of day 4 adult wild-type worms. Knockdown of cct 
subunits during adulthood reduces the number of germ line cells. RNAi was initiated at day 1 of 
adulthood. Scale bar represents 100 µm. The images are representative of two independent 
experiments. (c) Number of eggs laid per worm during 24 h. RNAi was initiated at day 1 of 
adulthood. We started counting the number of laid eggs after 1 day of RNAi treatment. Graph 
represents the mean ± s.e.m. of 5 independent experiments (in each independent experiment, we 
counted and averaged the number of eggs laid by 6 worms for each treatment). (d) Loss of cct subunits 
during adulthood does not significantly decrease lifespan of wild-type worms at 20°C. All the statistical 
comparisons were made using the log-rank (Mantel–Cox) method. All the statistical comparisons were 
made by Student’s t-test for unpaired samples. P-value: **** (P<0.0001). 
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To assess the expression of CCT subunits in somatic tissues of adult C. elegans, we 
generated a GFP transcriptional reporter construct for cct-8 gene. Although we did not 
observe GFP expression in germ cells as a result of germline silencing of transgenes (Kelly, 
Xu et al. 1997, McKay, Johnsen et al. 2003), these experiments confirmed wide expression of 
cct-8 in somatic cells including neurons or body wall muscle cells (Figure 13 a-b). Somatic 
expression pattern of cct-8 resembled other cct subunits (e.g., cct-1, cct-2 and cct-7) showing 
a high expression in pharynx and tail (McKay, Johnsen et al. 2003, Lundin, Srayko et al. 
2008) (Figure 13a-b). 
 
 
 
In aging organisms, post-mitotic somatic tissues undergo a gradual deterioration and 
become particularly susceptible to age-associated protein aggregation diseases. Thus, we 
asked whether increasing the levels of the TRiC/CCT complex in somatic tissues could delay 
the aging of post-reproductive organisms. To examine this hypothesis, we overexpressed 
CCT8, a subunit that promotes TRiC/CCT assembly in mammalian cells (Figure 14e). For 
this purpose, we induced ectopic expression of cct-8 under sur-5 promoter, which is 
Figure 13. cct-8 is widely expressed in somatic tissues. (a) Representative images of GFP 
expressed under control of the cct-8 promoter in whole adult worm. Scale bar represents 100 µm. 
Arrow indicates neurons. (b) Adult expression of GFP under cct-8 promoter in the head, mid-body 
and tail regions. Scale bar = 50 µm. The images are representative of three independent experiments. 
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expressed ubiquitously in somatic tissues but not in the germline (Gu, Orita et al. 1998, 
Vilchez, Morantte et al. 2012, Vilchez, Morantte et al. 2012). Notably, somatic 
overexpression (OE) of cct-8 was sufficient to extend the lifespan of C. elegans under normal 
conditions (20°C) (Figure 14b). These worms exhibited up to 20% increased median lifespan 
compared with the control strain and other cct-overexpressing worms (Figure 14b). Since 
overexpression of a single cct subunit did not change the levels of other subunits, the 
longevity phenotype can be attributed specifically to cct-8 (Figure 14a). Interestingly, the 
lifespan extension induced by ectopic expression of cct-8 was more dramatic at 25°C (Figure 
14c). Under this temperature, cct-8(OE) C. elegans lived up to 40% longer than the control 
strain. Overexpression of cct-2 also increased lifespan significantly at 25°C, although to a 
lesser extent than cct-8 (Figure 14c). Since heat stress challenges the structure of proteins and 
triggers the accumulation of misfolded proteins, our results indicate that both cct-8 and cct-2 
extend longevity by sustaining the integrity of the proteome during adulthood.  
 
To examine whether these pro-longevity effects are induced through modulation of the 
TRiC/CCT complex, we knocked down the expression of a different subunit. Given that cct 
subunits are required during larval development, we initiated RNAi treatment during 
adulthood. Interestingly, knockdown of cct-6 partially reduces the longevity phenotype of 
both cct-8(OE) and cct-2(OE) worms whereas it did not affect the lifespan of the control 
strain (Figure 14d). By native gel electrophoresis analysis, we confirmed that overexpression 
of cct-8 in somatic tissues increases TRiC/CCT assembly in the form of two stacked rings 
(Figure 14e). Collectively, these results suggest that ubiquitous somatic overexpression of cct-
8 induces longevity via modulation of TRiC/CCT assembly, particularly, under proteotoxic 
conditions. 
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Figure 14 Somatic increased expression of cct-8 induces TRiC/CCT assembly and extends 
longevity. (a) Data represent the mean ± s.e.m. of the relative expression levels to GFP(OE) worms (n= 4 
independent experiments). Statistical comparisons were made by Student’s t-test for unpaired samples. P-
value: **(P<0.01), **** (P<0.001). (b), (c) and (d) Each lifespan graph shows a Kaplan-Meier survival 
plot of a single representative experiment. In each graph, experimental and control animals were grown in 
parallel. n= total number of uncensored animals/total number (uncensored + censored) of animals 
observed in each experiment. P-values refer to experimental and control animals in a single lifespan 
experiment. (b) cct-8(OE) extends lifespan at 20°C (log rank, P<0.0001). GFP(OE): median= 14, n= 
73/96; cct-2, GFP(OE): median= 14, n= 65/96; cct-7, GFP(OE): median= 13, n= 46/74; cct-8, GFP(OE): 
median= 16, n= 70/96. (c) Both cct-8(OE) and cct-2(OE) worms live longer compared to control 
GFP(OE) strain at 25°C (log rank, P<0.0001). cct-8(OE) worms live longer compared with cct-2(OE) 
and other cct(OE) strains (log rank, P<0.0001). GFP(OE): median= 10, n= 89/96; cct-2, GFP(OE): 
median= 11, n= 79/96; cct-5, GFP(OE): median= 11, n= 42/50; cct-7, GFP(OE): median= 9, n= 56/77; 
cct-8, GFP(OE): median= 14, n= 82/96. (d) Knockdown of cct-6 reduces the long lifespan induced by 
cct-8(OE) (log rank, P= 0.0001). In contrast, loss of cct-6 does not decrease the lifespan of GFP(OE) 
worms. RNAi was initiated at day 1 of adulthood. GFP(OE) fed empty vector RNAi bacteria: median= 
10, n= 74/96; GFP(OE) fed cct-6 RNAi bacteria: median= 11, n= 73/96;  cct-8, GFP(OE) fed empty 
vector bacteria: median= 13, n= 77/96; cct-8, GFP(OE) fed cct-6 RNAi bacteria: median= 12, n= 79/96. 
(e) Native gel electrophoresis of GFP(OE) and cct-8,GFP(OE) worm extracts followed by 
immunoblotting with CCT-1 antibody (two different exposure times of the same membrane are shown). 
Overexpression of cct-8 induces an increase in the assembly of TRiC/CCT in the form of two stacked 
rings. (*) indicates a complex of approximately 475 kDa which is strongly detected in worm lysates. The 
molecular weight suggests that this signal could correspond to single ring TRiC/CCT assembled forms. 
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3.3.1.6 CCT-8 determines proteotoxic stress resistance 
 
During aging, organisms lose their ability to maintain proteostasis and respond to 
proteotoxic stress (Taylor and Dillin 2011, Lopez-Otin, Blasco et al. 2013). With age, the 
expression of several cct subunits significantly decreased in C. elegans whereas the levels of 
cct-1 remained similar (Figure 15a-b). At day 5 of adulthood, several cct subunits (e.g., cct-2, 
cct-5 and cct-8) were already downregulated (Figure 15a-b).  
 
To examine whether somatic cct-8(OE) ameliorates the age-associated demise in 
proteotoxic stress responses, we induced acute heat stress (34°C) at different ages (i.e., day 1 
and day 5). Severe heat stress dramatically affects survival and activates the heat-shock 
response (HSR), an essential mechanism to ensure proper cytosolic protein folding and 
alleviate proteotoxic stress (Vabulas, Raychaudhuri et al. 2010). Under heat stress (34°C), 
cct-8(OE) worms did not survive significantly longer compared with control strain at day 1 of 
adulthood (Figure 16a). However, cct-8(OE) worms were markedly more resistant to 
proteotoxicity than control strains when subjected to heat stress at day 5 of adulthood (Figure 
16b). Although to a lesser extent, cct-2(OE) also conferred resistance to heat stress (Figure 
16b). As a more formal test, we asked whether animals with reduced HSR had increased 
survival when cct-8 was overexpressed (Figure 16b). Heat-shock transcription factor (HSF-1) 
activates the HSR and is required for proteotoxicity resistance and adult lifespan (Morimoto 
2011). Thus, we induced downregulation of HSR via silencing hsf-1 expression. Notably, hsf-
1-RNAi-treated cct-8(OE) worms lived markedly longer compared to control worms under 
 
Figure 15 Expression of specific cct subunits decrease with age. (a) The expression of several cct 
subunits decreases with age. In contrast, we did not find significant differences in cct-1 and enpl-1, the 
C. elegans orthologue to the human chaperone HSP90B1. Data represent the mean ± s.e.m. of the 
relative expression levels to day 1 adult worms grown at 20°C or 25°C (b) These experiments were 
performed with the sterile control strain fer-15(b26)II;fem-1(hc17) (n= 4 independent experiments). 
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the same treatment (Figure 16c). These results indicate that cct-8(OE) C. elegans can 
significantly overcome the loss of a key transcription factor such as hsf-1, which is not only 
required for HSR but also lifespan.  
 
 
Growing evidence suggest that the TRiC/CCT complex could be a therapeutic target 
in Huntington’s disease (HD) (Kitamura, Kubota et al. 2006, Tam, Geller et al. 2006). For 
instance, simultaneous overexpression of all eight CCT subunits ameliorates polyQ-expanded 
HTT aggregation and neuronal death (Kitamura, Kubota et al. 2006). Intrigued by the 
protection that cct-8 could confer, we tested whether increased levels of this subunit are 
sufficient to protect from polyQ-expanded aggregation. For this purpose, we used a C. 
elegans model that expresses polyQ peptides throughout the nervous system. In these worms, 
neurotoxicity correlates with increased length of the polyQ repeat and age (Brignull, Moore et 
al. 2006, Vilchez, Boyer et al. 2012). The neurotoxic effects can be monitored by worm 
motility, which is markedly reduced by the aggregation of polyQ peptides with a pathogenic 
threshold at a length of 35–40 glutamines (Brignull, Moore et al. 2006). We found that 
ectopic expression of cct-8 reduced toxicity and improve motility of worms expressing 
polyQ67 either at 20°C or 25°C (Figure 17a-b). Similarly, cct-2(OE) also ameliorated the 
neurotoxic effects of polyQ67 aggregation although the impact of cct-8 is more dramatic 
Figure 16  cct-8 determines proteotoxic stress resistance during aging. (a). When subjected to heat 
stress (34°C) at day 1 of adulthood, both cct-8(OE) and cct-2(OE) worms show similar survival rates 
compared with the control strain (GFP(OE): median= 11, n= 70/72; cct-2, GFP(OE): median= 10, n= 
71/72; cct-8, GFP(OE): median= 9, n= 70/72). (b) In contrast, cct-8(OE) (log rank, P<0.0001) and cct-
2(OE) (log rank, P=0.0036) worms survive longer than control strain when subjected to heat stress at 
day 5 of adulthood (GFP(OE): median= 14, n= 57/58; cct-2, GFP(OE): median= 16, n= 57/57; cct-8, 
GFP(OE): median= 17, n= 57/57). (c) hsf-1-RNAi-treated cct(OE) worms were long-lived compared to 
control strain under the same treatment (log rank, P<0.0001). RNAi was initiated at day 1 of adulthood. 
GFP(OE) fed hsf-1 RNAi bacteria: median= 7, n= 90/96; cct-2, GFP(OE) fed hsf-1 RNAi bacteria: 
median= 8, n= 82/96; cct-8, GFP(OE) fed hsf-1 RNAi bacteria: median= 9, n= 72/96. 
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(Figure 17a-b). Moreover, filter trap analysis showed that cct-8(OE) reduced polyQ67 
aggregates without decreasing the total protein levels of polyQ67 (Figure 17c). In fact, we 
observed higher expression of total polyQ67 protein in cct-8(OE) worms probably because 
they are in a healthier state than controls. Taken together, these results indicate CCT8 as a 
novel candidate to sustain proteostasis during aging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 cct-8 protects from polyQ aggregation. (a-b). Ectopic expression of cct-8 and cct-2 
improves motility in polyQ67 worms at 20 and 25°C. In the left panel, each point represents the 
average thrashing rate of a single 3 day-adult animal over a period of 30 s. In the right panel, bar 
graphs represent average ± s.e.m. of these data (GFP(OE);Q67 (n= 37),  cct-2,GFP(OE);Q67 (n= 38), 
cct-8,GFP(OE);Q67 (n= 38)). All the statistical comparisons were made by Student’s t-test for 
unpaired samples. P-value: ***(P<0.001), **** (P<0.0001). (c) Filter trap indicates that cct-8 
overexpression results in decreased polyQ aggregates (detected by anti-GFP antibody). Right panel: 
SDS-PAGE analysis with antibodies to GFP and α-tubulin loading control. 
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Longevity-promoting pathways such as reduced insulin–insulin-like growth factor 
(IGF) signaling (IIS) and dietary restriction (DR) delay the onset of age-related diseases 
associated with proteostasis dysfunction (Vilchez, Saez et al. 2014). These pathways confer 
increased proteome integrity and resistance to proteotoxic stress during aging (Taylor and 
Dillin 2011, Vilchez, Saez et al. 2014), mechanisms that contribute to lifespan extension. 
Thus, we hypothesized that the TRiC/CCT complex could be required for the longevity 
phenotype induced by IIS and DR. Notably, loss of function of TRiC/CCT complex 
significantly decreased longevity of long-lived IIS and DR genetic models whereas it did not 
affect the lifespan of wild-type worms (Figure 18a). In C. elegans, the aging of somatic 
tissues is regulated by signals from the germline (Kenyon 2010). Concomitantly, ablation of 
germ cells extends lifespan and induces heightened resistance to proteotoxic stress in post-
mitotic tissues (Vilchez, Morantte et al. 2012, Khodakarami, Mels et al. 2015). We found that 
TRiC/CCT dysfunction reduces the lifespan of germline-lacking genetic worm models 
(Figure 18b). We have previously reported that removal of germ cells induces increase 
expression of key proteasome subunits in somatic tissues (Vilchez, Morantte et al. 2012). An 
intriguing possibility is that the germline also modulates the expression of CCT subunits in 
somatic tissues. Indeed, germline-lacking C. elegans showed up-regulation of CCT 
expression in somatic tissues (Figure 18d). Altogether, our data suggest that the TRiC/CCT 
complex could be a key determinant of longevity and proteotoxic resistance (Kitamura, 
Kubota et al. 2006). 
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Figure 18 TRiC/CCT is required for the longevity phenotype of long-lived C. elegans mutants. 
(a) Knockdown of cct-8 decreases lifespan of IIS (daf-2) and DR (eat-2) long-lived mutant worms at 
20°C (log rank, P<0.0001). N2 (wild-type worms) + vector RNAi: median= 17, n= 72/9; N2 + cct-8 
RNAi: median= 19, n= 66/96; eat-2(ad1116) + vector RNAi: median= 23, n= 66/96; eat-2(ad1116) + 
cct-8 RNAi: median= 18, n= 67/96; daf-2(e1370) + vector RNAi: median= 37, n= 68/96; daf-2(e1370) + 
cct-8 RNAi: median= 31, n= 77/96. (b) Knockdown of cct-8 decreases lifespan of germline-lacking 
mutant worms (log rank, Po0.0001). glp-1(e2141).vector RNAi: median.21, n.88/96; glp-1(e2141).cct-8 
RNAi: median.16, n.86/96. (c) Gonad and intestine immunostaining with CCT-1 antibody from wild-
type and germline-lacking (glp-1(e2141)) worms. Long-lived germline-lacking nematodes have 
increased levels of CCT-1 in the intestine compared to wild-type worms. Cell nuclei were stained with 
DAPI. White arrow indicates gonad and red arrow indicates intestine. Scale bar represents 50 µm. (d) 
Representative images of GFP expressed under control of the cct-8 promoter in adult wild-type and 
germline-lacking (glp-1(e2141)) worms. Scale bar represents 100 µm. In c and d the images are 
representative of three independent experiments. See Supplementary Data 3 for statistical analysis and 
replicate data of lifespan experiments. 
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4 Discussion 
 
4.1 Investigating the role of PSME4 in stem cells and aging 
 
 
 
Investigating the proteostasis of pluripotent cells in order to find regulators of stress 
resistance and longevity is an important and interesting field of biological research which has 
been emerging only in the recent years (Vilchez, Boyer et al. 2012, Vilchez, Simic et al. 
2014). The knowledge gained from this line of research could not only be of crucial 
importance for better understanding stem cell and developmental biology, but regarding the 
central role of stem cells and proteostasis in the aging process (Lopez-Otin, Blasco et al. 
2013) could pave the way towards development of novel therapies with wide application 
against age-associated diseases. In this work, we concentrated on the UPS system and the 
chaperome network, two of the main proteostasis components in hESCs.  
 
The ubiquitin proteasome system is the major proteolytic system in eukaryotic cells 
(Meiners, Heyken et al. 2003). Previous findings showed that hESCs exhibit enhanced 
assembly of 26S/30S active proteasomes induced by increased levels of the 19S subunit 
PSMD11/RPN-6 (Vilchez, Boyer et al. 2012, Vilchez, Morantte et al. 2012). In addition to 
regulation by 19S, the core particle can be activated by other regulatory particles such as 
PSME4 (also known as the proteasome activator 200, PA200). PSME4 is a monomeric 
protein of 250 kDa and in contrast to the 19S regulatory particle; PSME4 can activate the core 
proteasome without having ATPase or ubiquitin binding properties. PSME4 can form hybrid 
complexes in which this protein binds to one end of the 20S proteasome and the 19S to the 
opposite end. PSME4 has been suggested to be essential for spermatogenesis and DNA repair, 
but the precise biological functions remain controversial and poorly understood (Savulescu 
and Glickman 2011). Therefore, understanding its impact on hESCs function not only has 
implications in hESC function but also in defining the cellular role of this protein. 
 
We discovered that expression of PSME4 is remarkably elevated in hESCs compared 
to differentiated cells of ectodermal or mesodermal lineages. On the other hand, It is 
interesting that the expression of PSME4 is dramatically increased upon endodermal 
differentiation, which might hint towards special function of this protein in the endoderm 
lineage. Moreover, regulation of PSME4 expression is reprogrammable (Figure 1a-e). 
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However, the stem cells were not affected by downregulation of PSME4 (Figure 2). This was 
demonstrated by the intact expression of major pluripotency markers such as OCT4, NANOG 
and SOX2, and absence of any difference in expression of difference lineage markers such as 
AFP and MSX in PSME4 KD hESCs. There are some significant differences in expression of 
a subset of markers, but for all of these markers, this difference could only be observed in one 
of the KD lines. Based on the observation that the PSME4 knockdown is quite efficient in 
both cell lines infected with either shRNA (Figure 1 e-f), and the capability of downregulated 
PSME4 cells to differentiate into endodermal or neural lineages (Figure 2b-c) this could be 
interpreted as off target side effects of the lentiviral transduction than a biologically relevant 
consequence of lesser PSME4 levels. The reasons behind the lack of any obvious 
consequence upon PSME4 downregulation could be diverse. It is known that cells possess 
complex adaptive mechanisms to compensate for interference in the proteasome (Meiners, 
Heyken et al. 2003). To prevent this, we also used transient lentiviral infections, and checked 
for different marker expression and differentiations, but could not detect any changes (data 
not shown). It is therefore plausible that other genes can compensate for lack of PSME4 under 
normal conditions. PSME4 is mainly localized in the nucleus and has been suggested to have 
a role in DNA repair (Ustrell, Hoffman et al. 2002). Stem cells have been shown to have 
enhanced DNA damage repair mechanisms such as error free homologous recombination 
(HR) and non-homologous end joining (NHEJ) (Durante 2011). This leads to lesser 
accumulation of spontaneous mutations compared to somatic cells, and the capability to 
maintain self-renewal and genomic stability (Maynard, Swistowska et al. 2008, Frosina 
2010). However, previous studies suggest that murine and human neural stem cell precursors 
demonstrate higher sensitivity to ionizing radiation (Nowak, Etienne et al. 2006, 
Panagiotakos, Alshamy et al. 2007). Interestingly, PSME4 has been shown to enhance the 
post-glutamyl activity of the proteasome and regulate cellular resistance to IR (Blickwedehl, 
Agarwal et al. 2008) (Blickwedehl, Olejniczak et al. 2012). It could be therefore hypothesized 
that higher levels of PSME4 in hESCs provides them with more protection against IR induced 
DNA damage. Taken the impact of PSME4 in response to DNA damage (Ustrell, Hoffman et 
al. 2002), further studies are required to shed light on lineage specific role of this protein in 
DNA damage repair in stem cells. Moreover, it could be interesting to challenge the hESCs 
with different stress conditions and check if their function is affected. It is also interesting to 
knockdown/overexpress PSME4 in cells derived from patients suffering from protein 
misfolding diseases and to investigate the effects, as it has been suggested that PSME4 is 
mainly involved in degradation of peptides and unstructured proteins (Tar, Dange et al. 2014).  
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Taken together, from the experiments shown here it could be concluded that PSME4 is 
not vital for hESCs under normal conditions and might only be responsible for specific 
functions in particular lineages and/or under specific conditions. 
 
Investigating the biology of PSME4 in C. elegans faces an extra hurdle: the gene has 
two orthologues in worms. In this work, we mainly concentrated on C14C10.5, which 
exhibits more similarity to human PSME4 in the amino acid sequence (Figure 3a). 
Maintaining a balanced proteostasis is crucial for healthy ageing and longevity. We therefore 
asked whether manipulation of psme4 could lead to accumulation of protein damage and 
affect lifespan. By using RNAi and creating extrachromosomal arrays we studied the impact 
of psme4 downregulation or overexpression on longevity and stress resistance in C. elegans. 
We were not able to detect any significant changes in the lifespan of worms, neither under 
normal growth conditions (20°C) or mild proteotoxic stress (25°C) (Figure 3b-f). 
 
Lack of any spectacular phenotypes in hESCs and C.elegans lifespan under normal 
conditions motivated us to study the impact of psme4 for stress resistance. Interestingly, we 
observed that the worms downregulated for psme4 live longer than control worms. Reversely, 
overexpression of psme4 lead to a minor, but significant, decrease in heat stress resistance of 
worms (Figure 4). This observation could be because psme4 does not play a major role in the 
clearance of heat-damaged proteins, and its presence in the assembled proteasomes shifts the 
balance towards proteasome species, which are inactive against heat stress, thus reducing the 
overall survival of the organism. We went further to ask whether psme4 might be important 
for resistance against oxidative stress. Whereas downregulation of psme4 did not affect the 
survival of worms, we observed a small yet significant increase in the survival of one of the 
overexpression lines. The difference between the two lines can be explained by the fact that 
these lines are not integrated, and overexpression levels might vary to some extent among 
different lines. Taken the dramatic changes in protein oxidation levels during differentiation, 
and the role of 20S proteasome in clearance of this damaged proteins (Hernebring, Brolén et 
al. 2006), we asked whether psme4 could play a role in clearance of oxidized proteins in this 
conditions. As we observed a major increase in PSME4 expression in early endoderm 
progenitors, we performed OxyBlot analysis both in hECSs and endoderm progenitors (Figure 
4e). Although we once observed an increase in the levels of oxidized proteins in endoderm 
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cells downregulated for PSME4 (Data not shown) this effect was not observed in any of the 
following experimental replicates, and thus could not be confirmed.  
 
 Interestingly, a recent study hints towards a role for Psme4 in antioxidant response 
(Huang, Haratake et al. 2016). In this study, it is suggested that deletion of Psme4, together 
with another proteasome activator PA28γ (or PSME3, which also shows elevated expression 
in hESCs compared to differentiated counterparts) leads to complete male infertility in mice. 
These double knockout (dKO) sperms showed compromised functionality and motility, as 
well as reduced proteasome activity and accumulation of oxidative damage (Huang, Wang et 
al. 2014). This confirms our hypothesis that lack of PSME4 alone could be somehow 
compensated, by other proteostasis mechanisms in the cells, and the cells could cope with its 
absence, unless confronted with specific stress, or additional burden of missing an extra 
proteasome subunit.  
 
4.2 Investigating the role of TRiC/CCT in stem cells and 
aging 
 
Despite the recent studies, which link the UPS in hESCs and organismal aging, a 
comprehensive study of the role of molecular chaperones in stem cell biology has yet been 
missing. By using quantitative proteomics and RNA sequencing, we compared the expression 
levels of components of the chaperome network in hESCs to differentiated cells. At the 
protein level, for instance, we found that 36 out of 122 identified chaperome components 
decrease during differentiation into NPCs. In contrast, 27 chaperome components were 
increased during neural differentiation. Taken the important role of TRiC/CCT complex in 
cellular ptoteostasis, we concentrated in studying the role of this huge molecular machine in 
stem cell biology. Our findings establish enhanced assembly of the TRiC/CCT complex as an 
intrinsic characteristic of pluripotent stem cells. This increased assembly correlates with an 
up-regulation of several CCT subunits. Notably, hESCs are able to maintain high expression 
of CCT subunits during unlimited proliferation. However, hESCs lose their high levels of 
CCT subunits upon differentiation and this decline is already significant in multipotent cells 
(e.g., NPCs) before terminal differentiation (Figure 5). Therefore, enhanced TRiC/CCT 
assembly could be linked to the immortal and pluripotent characteristics of hESCs/iPSCs. 
Indeed, we found that slight dysfunctions of the TRiC/CCT complex induce a decrease in 
pluripotency markers and, concomitantly, an increase in differentiation markers. Defining the 
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mechanisms by which increased TRiC/CCT regulates hESC identity could open a new door to 
a better understanding of pluripotency and differentiation. Although the exact mechanisms are 
still unknown, the TRiC/CCT complex could impinge upon hESC function in several (and 
non-exclusive) manners. TRiC/CCT assists the folding of a significant percentage of nascent 
proteins such as actin and tubulin (Gao, Thomas et al. 1992, Yam, Xia et al. 2008). Thus, one 
possibility is that enhanced TRiC/CCT assembly is required for the proper folding of specific 
regulatory or structural proteins involved either in maintenance of hESC identity or 
generation of healthy differentiated cells. Interestingly, a study performed in calreticulin-/- 
mouse ESCs showed a downregulation in the expression of Cct2, Cct3 and Cct7 (Faustino, 
Chiriac et al. 2010) in these cells. Calreticulin, a chaperone that binds to misfolded proteins 
preventing their export from the endoplasmic reticulum, is essential for cardiac development 
in mice (Mesaeli, Nakamura et al. 1999) and required for proper myofibril formation during 
cardiomyocyte differentiation of mouse ESCs in vitro (Li, Puceat et al. 2002). Since the 
TRiC/CCT complex regulates folding and actin dynamics, the downregulation of Cct subunits 
in calreticulin-/- mouse ESCs could forecast the myofibrillar disarray observed in their 
cardiomyocytes counterparts (Faustino, Chiriac et al. 2010). As TRiC/CCT also regulates the 
aggregation of misfolded and damaged proteins, increased TRiC/CCT levels could be linked 
to the biological purpose of pluripotent stem cells and their intrinsic properties such as high 
global protein synthesis, proliferation rates and immortality.  
 
hESCs exhibit a distinct cell cycle signature  and high proliferation rates has been 
shown to be essential for maintenance of hESC identity as well as reprogramming efficiency 
(Ruiz, Panopoulos et al. 2011). CCT is responsible for folding of many cell cycle 
components, such as Plk1, whose activity is required for the mammalian cells to enter mitosis 
(Liu, Lin et al. 2005). Thus CCT could also be an essential factor in regulating cell cycle and 
proliferation rate of hESCs. Increased levels of translation is another characteristic of ESCs in 
comparison to differentiated cells (You, Park et al. 2015). CCT is also directly involved in 
regulating the translation rate, at least by regulating the folding of three subunits of the 
translation initiation factor eIF3 (Roobol, Roobol et al. 2014). Telomere length is another key 
factor, which is essential for maintaining the proliferative potential and replicative 
immortality of stem cells (Allen and Baird 2009). ESCs have increased telomerase activity, 
and this higher activity is not only required for stem cell self-renewal and extended lifespan, 
but also enhances stress resistance by influencing stress response genes (Armstrong, Saretzki 
et al. 2005). CCT has recently be discovered to be a critical regulator of telomerase trafficking 
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by folding the telomerase cofactor TCAB1 (Freund, Zhong et al. 2014). Lack of CCT was 
shown to cause mislocalization of telomerase, and failure of telomere elongation due to lack 
of TCAB1 (Freund, Zhong et al. 2014). Together, it could be concluded that various aspects 
of stem cell biology are directly regulated by CCT, and lack of CCT activity could have more 
detrimental consequences for stem cells compared to differentiated ones.  
 
Given the ability of hESCs to replicate indefinitely and generate every other cell type 
in the body, the TRiC/CCT complex could be a key quality control mechanism to maintain a 
global intact proteome for either self-renewal or the generation of progenitor cells. In this 
context, the accumulation of damaged and misfolded proteins caused by proteostasis defects 
may affect hESCs function and immortality. With the asymmetric divisions invoked by these 
cells, the passage of damaged proteins to progenitor cells could also compromise 
development and organismal aging. In support of this hypothesis, we found that the 
TRiC/CCT complex determines the ability of iPSCs to maintain proteostasis of mutant 
huntingtin. 
 
Another important question is how hESCs achieve their high TRiC/CCT levels. 
Interestingly, specific subunits such as CCT4 are relatively more abundant compared to CCT1 
in hESCs whereas this proportion is reversed in NPCs (Figure 7). Therefore, these subunits 
could become limiting assembly factors during differentiation. Despite decreasing during 
neural differentiation, other CCT subunits (i.e., CCT8 and CCT2) were more abundant 
relatively to the rest of subunits in both hESCs and NPCs suggesting that they could be 
activators of TRiC/CCT assembly rather than limiting factors. Indeed, increasing the 
expression of CCT8, the most abundant subunit, triggers TRiC/CCT assembly regardless the 
levels of other subunits such as CCT1 in both mammalian cells and C. elegans. Further 
studies will be required to understand how CCT8 promotes TRiC/CCT assembly. A 
fascinating hypothesis is that CCT8 could act as a scaffold protein that triggers the interaction 
between the different subunits.  
 
Our findings in human pluripotent stem cells led us to identify CCT8 as a powerful 
candidate to sustain proteostasis during organismal aging. The somatic induction of 
TRiC/CCT assembly via CCT8 overexpression extends lifespan and protects from proteotoxic 
stress in C. elegans. Notably, somatic CCT8 overexpression can partially protect this 
nematode from knockdown of hsf-1, a transcription factor that coordinates cellular protein-
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misfolding responses. The precise mechanism by which the TRiC/CCT complex ameliorates 
the detrimental effects triggered by loss HSF1 is not yet understood. In response to 
proteotoxic stress, HSF1 binds heat shock elements (HSE) in the promoters of target genes 
and triggers their expression (Akerfelt, Morimoto et al. 2010). In mammalian cells, all the 
CCT subunits contain HSE and are transcriptionally activated by HSF1 (Kubota, Matsumoto 
et al. 1999). Thus, ectopic expression of CCT8 could ameliorate the effects induced by a 
decrease of CCT subunits upon HSF1 knockdown. In addition, a direct regulatory interaction 
between TRiC/CCT activity and induction of proteotoxic-stress response by HSF1 has been 
recently reported (Neef, Turski et al. 2010, Neef, Jaeger et al. 2014). HSF1A, a chemical 
activator of HSF1, binds to the TRiC/CCT complex and inhibits its folding activity (Neef, 
Turski et al. 2010, Neef, Jaeger et al. 2014). Both the inactivation of TRiC/CCT complex by 
HSF1A or its depletion by loss of CCT subunits induce HSF1 activity (Neef, Jaeger et al. 
2014). Since TRiC/CCT chaperonin interacts with HSF1(Neef, Jaeger et al. 2014), TRiC/CCT 
could have a direct repressor role in regulating HSF1 (Neef, Jaeger et al. 2014). However, a 
decrease in TRiC/CCT activity mediated by either HSF1A or knockdown of CCT subunits 
can also lead to the accumulation of misfolded proteins that trigger the HSF1-induced 
proteotoxic response (Neef, Jaeger et al. 2014). In support of this hypothesis, our results 
suggest that increased TRiC/CCT assembly induced by CCT8 reduces the accumulation of 
misfolded proteins and, therefore, ameliorates the deleterious impact of reduced HSF1-
mediated signaling. 
 
During organismal aging, loss of proteostasis in somatic tissues could contribute to the 
late onset of age-related diseases such as HD (Lopez-Otin, Blasco et al. 2013, Brehme, 
Voisine et al. 2014). Hence, the decrease in the levels of several CCT subunits during human 
brain aging (Brehme, Voisine et al. 2014) may induce TRiC/CCT dysfunction, proteotoxic 
stress and neurodegeneration. In support of this hypothesis, knockdown of CCT subunits 
hastens aggregation of mutant HTT and worsens HD-related changes in HD models (Nollen, 
Garcia et al. 2004, Kitamura, Kubota et al. 2006, Tam, Geller et al. 2006, Brehme, Voisine et 
al. 2014). Previous studies have shown that simultaneous overexpression of all eight CCT 
subunits ameliorates polyQ-expanded HTT aggregation and neuronal death (Kitamura, 
Kubota et al. 2006). Furthermore, overexpression of CCT1 remodels the morphology of HTT 
aggregates and reduces neurotoxicity (Tam, Geller et al. 2006). Although CCT1 
overexpression does not increase TRiC/CCT assembly, this subunit modulates the interaction 
between HTT and TRiC/CCT complex (Tam, Geller et al. 2006). Moreover, a recent study 
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showed that both CCT3 and the apical domain of CCT1 are able to enhance the transport of 
brain-derived neurotrophic factor (BDNF) and lysosomes in axons and rescue striatal atrophy 
in HD models by reducing the mutant HTT (Zhao, Chen et al. 2016). Since CCT8 is sufficient 
to increase TRiC/CCT assembly, this subunit could be a candidate to correct deficiencies in 
age-related diseases associated with proteostasis dysfunction. Indeed, we found that 
overexpression of CCT8 can protect from the accumulation of polyQ-expanded proteins. 
Recently, a link between CCT8 and mutant HTT expression was observed in an integrated 
genomics and proteomics study of knock-in HD mouse models expressing the human HTT 
exon1 carrying different CAG lengths (polyQ20, Q80, Q92, Q111, Q140 or Q175) 
(Langfelder, Cantle et al. 2016). Notably, highly expanded-polyQ HTT exon1 (Q175) induces 
a significant increase of CCT8 at both transcript and protein levels in the striatum of young 
mice (6-months) whereas other subunits were not altered (Langfelder, Cantle et al. 2016). In 
contrast, CCT8 induction was not observed in knock-in mice expressing mutant HTT with 
lower than 175 polyQ repeats. These findings suggest that up-regulation of CCT8 could be a 
compensatory mechanism to protect from polyQ aggregation.  
 
While expression of CCT subunits decrease during both differentiation and biological 
aging, our results indicate that mimicking proteostasis of hESCs by modifying either the 
chaperome or proteasome network (Vilchez, Boyer et al. 2012) delays the aging of somatic 
cells and extends organismal lifespan. Given the link between sustained proteostasis in somatic 
cells and healthy aging, our findings raise an intriguing question: why the levels of CCT8 
decrease during differentiation if this subunit could have beneficial effects on organismal 
longevity and proteotoxic stress resistance? In this regard, it is important not to diminish 
potential detrimental effects of mimicking proteostasis of ESCs in somatic tissues. For instance, 
cancer cells and ESC not only share their immortality features but also increased proteostasis 
nodes such as proteasome activity and specific chaperones (Whitesell and Lindquist 2005, Saez 
and Vilchez 2014, Vilchez, Simic et al. 2014). Proteasome and chaperone levels in cancer cells 
are consistent with the special requirements of these cells, such as elimination of aberrant 
proteins. Interestingly, the expression of CCT8 is increased in gliomas and hepatocellular 
carcinoma whereas its knockdown induces a decrease in the proliferation and invasion 
capacity of these cells (Huang, Wang et al. 2014, Qiu, He et al. 2015). Similarly, other CCT 
subunits have been linked to cancer including colorectal carcinoma and breast cancer 
(Boudiaf-Benmammar, Cresteil et al. 2013). Whereas proteasome inhibitors and interventions 
of the chaperone network have been suggested as potential strategies for anticancer therapy 
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(Whitesell and Lindquist 2005, Rappa, Farina et al. 2012), an abnormal activation of these 
mechanisms in somatic dividing cells could have the opposite effect inducing their abnormal 
proliferation. However, although the TRiC/CCT complex is important for the proliferation of 
cancer cells, this chaperonin is also required for the proper folding of p53 and, therefore, 
promotes tumor suppressor responses (Trinidad, Muller et al. 2013). Thus, the TRiC/CCT 
complex could be an important factor to avoid misfolding of tumor suppressors and the 
increase incidence of cancer during the aging process. Besides its link with cancer, other 
factors could explain the decline of CCT subunits during differentiation. In support of the 
disposable soma theory of aging (Kirkwood 1977), a fascinating hypothesis is that 
downregulation of the TRiC/CCT complex during differentiation is part of an organismal 
genetic program that ensures a healthy progeny whereas somatic tissues undergo a 
progressive demise in their homeostasis and function. Due to the limitation of nutrients in 
nature, organisms divide the available metabolic resources between reproduction and 
maintenance of the non-reproductive soma. Evolutionary pressure has been theorized to force 
a re-allocation of the resources to prevent or eliminate damage to the germline and progeny, 
while little resources are placed on the maintenance of somatic cells (Kirkwood 1977). In 
support of this hypothesis, signals from the germline modulate the aging of somatic tissues 
and removal of the germline extends lifespan (Khodakarami, Mels et al. 2015). Interestingly, 
our results indicate that germline-lacking worms exhibit increased levels of TRiC/CCT in 
post-mitotic cells. 
 
 
Conclusion 
Collectively, we underscore the importance of defining proteostasis of hESCs to 
uncover novel mechanisms of organismal healthspan extension. Besides CCT subunits, other 
chaperome components also demonstrate differential expression during differentiation and, 
therefore, could be interesting targets to be studied in the context of aging. In addition, it will 
be fascinating to explore whether and how other proteostasis components such as autophagy, 
HSR, UPRER and UPRmt are also divergent in hESCs, whether they impact stem cell 
pluripotency and self-renewal and if mimicking these mechanisms in somatic cells, tissues or 
whole organisms can extend organismal healthspan or ameliorate disease related pathologies. 
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